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Structured Abstract
Objectives: The purpose of this report is to systematically examine the possible causal 
mechanism(s) that may explain the association between alcohol (ethanol) consumption and the 
risk of developing breast and colorectal cancers.
Data Sources: We searched 11 external databases, including PubMed and EMBASE, for studies 
on possible mechanisms. These searches used Medical Subject Headings and free text words to 
identify relevant evidence. 
Review Methods: Two reviewers independently screened search results, selected studies to be
included, and reviewed each trial for inclusion. We manually examined the bibliographies of
included studies, scanned the content of new issues of selected journals, and reviewed relevant 
gray literature for potential additional articles. 
Results:
Breast Cancer. Five human and 15 animal studies identified in our searches point to a connection 
between alcohol intake and changes in important metabolic pathways that when altered may
increase the risk of developing breast cancer. Alterations in blood hormone levels, especially
elevated estrogen-related hormones, have been reported in humans. Several cell line studies 
suggest that the estrogen receptor pathways may be altered by ethanol. Increased estrogen levels 
may increase the risk of breast cancer through increases in cell proliferation and alterations in 
estrogen receptors. Human studies have also suggested a connection with prolactin and with 
biomarkers of oxidative stress. Of 15 animal studies, six reported increased mammary
tumorigenesis (four administered a co-carcinogen and two did not). Other animal studies 
reported conversion of ethanol to acetaldehyde in mammary tissue as having a significant effect 
on the progression of tumor development. Fifteen cell line studies suggested the following
mechanisms: 
increased hormonal receptor levels
increased cell proliferation
a direct stimulatory effect
DNA adduct formation
increase cyclic adenosine monophosphate (cAMP)
change in potassium channels
modulation of gene expression.
Colorectal Cancer. One human tissue study, 19 animal studies (of which 12 administered a co-
carcinogen and seven did not), and 10 cell line studies indicate that ethanol and acetaldehyde
may alter metabolic pathways and cell structures that increase the risk of developing colon 
cancer. Exposure of human colonic biopsies to acetaldehyde suggests that acetaldehyde disrupts
epithelial tight junctions. 
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Among 19 animal studies the mechanisms considered included:
mucosal damage after ethanol consumption
increased degradation of folate
stimulation of rectal carcinogenesis
increased cell proliferation
increased effect of carcinogens. 
Ten cell line studies suggested: 
folate uptake modulation
tumor necrosis factor modulation
inflammation and cell death
DNA adduct formation
cell differentiation
modulation of gene expression.
One study used a combination of animal and cell line and suggested intestinal cell proliferation 
and disruption of cellular signals as possible mechanisms.
Conclusions: Based on our systematic review of the literature, many potential mechanisms by
which alcohol may influence the development of breast or colorectal cancers have been explored 
but the exact connection or connections remain unclear. The evidence points in several directions 
but the importance of any one mechanism is not apparent at this time.
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Executive Summary
Alcohol Consumption and Cancer Risk: 
Understanding Possible Mechanisms for Breast 
and Colorectal Cancers
The purpose of our assessment of alcohol and cancer induction is to explore the possible
underlying causal mechanism(s) of the association between alcohol consumption and breast and 
colorectal cancers. Therefore, we developed four Key Questions that address the potential 
mechanism(s) by which alcohol might be involved in the development of breast and colorectal 
cancers. The primary evidence base to address these questions consisted of experimental studies 
of humans, animals, and cell lines where alcohol exposure could be controlled. In addition to this 
evidence base we also considered epidemiology studies where alcohol exposure was not
controlled (including those in patients with or without cancer) and hypothesis-generating studies 
that examined potential metabolic pathways connecting alcohol to cancer risk. These studies 
were considered in a separate evidence base that did not directly address the Key Questions.
Methods
The following Key Questions will be addressed in this report:
1.	 What are the likely causal mechanisms by which alcohol contributes to the development of
breast cancer? Which of the possible mechanisms (e.g., induction of P450 cytochromes and 
carcinogen metabolism, effects on blood hormone concentrations, effect of acetaldehyde or 
other alcohol metabolite on apoptosis and DNA repair, interactive effects on other 
nutritional factors, or others) are likely to be most important in breast cancer development?
2.	 For the most likely mechanisms of action involving alcohol and the development of breast 
cancer, how might other factors modify the effect of alcohol on breast cancer (for example, 
age, latency of effect, intensity, duration, and recency of exposure, presence of co-
carcinogens, presence of threshold effect)? Do the causal mechanisms vary by cell type or 
other tumor characteristics?
3.	 What are the likely causal mechanisms by which alcohol contributes to the development of
colorectal cancer? Which of the possible mechanisms (e.g., induction of P450 cytochromes 
and carcinogen metabolism, effects on blood hormone concentrations, effect of acetaldehyde
or other alcohol metabolite on apoptosis and DNA repair, interactive effects on other 
nutritional factors, or others) are likely to be most important in colorectal cancer 
development?
4.	 For the most likely mechanisms of action involving alcohol and the development of
colorectal cancer, how might other factors modify the effect of alcohol on colorectal cancer 
(for example, age, latency of effect, intensity, duration, and recency of exposure, presence of 
co-carcinogens, presence of threshold effect)? Do the causal mechanisms vary by cell type
or other tumor characteristics?
To address these Key Questions we searched electronic databases for information on ethanol 
consumption and the possible risks for breast and colorectal cancers. Thirty-five breast cancer 
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studies (five in humans, 15 in animals, and 15 in cell lines) and 31 colorectal cancer studies (one
in humans, 19 in animals, 10 in cell lines, and one combination [animal and cell lines]) were
included in the report. Information on study design and conduct was used to judge individual 
study internal validity. Data on experimental model, mechanism(s) examined, amount and 
duration of ethanol exposure, cancer formation, and intermediate outcomes were abstracted and
tabled for review and discussion.
Evidence for Alcohol Consumption and Cancer Risk: 

Understanding Possible Mechanisms for Breast and 

Colorectal Cancers
 
Breast Cancer Studies
Human studies. We included five studies to evaluate the possible mechanisms for alcohol 
consumption and breast cancer risk: the first study examined effects of alcohol on estradiol, 
estrone, estrone sulfate, testosterone, androstenedione, progesterone, dehydroepiandrosterone
(DHEA), DHEA sulfate (DHEAS), and androstenediol; the second study examined the effects of 
alcohol on plasma and urinary hormone concentrations in premenopausal women; a third study
examined the effect of alcohol on prolactin levels in menopausal women using estradiol
replacement; a fourth study examined the effects of alcohol on estrogen levels in postmenopausal 
women; and a fifth study examined the relationship of alcohol consumption with antioxidant 
nutrients and biomarkers of oxidative stress. Although none of these five studies reported direct 
evidence of cancer, we included them given that alcohol was administered to assess possible 
hormonal mechanism(s) and biomarkers of oxidative stress.
Animal studies. We included 15 studies using animal models to evaluate the possible mechanisms 
for alcohol consumption and breast cancer risk. Outcomes measured varied across studies. Of the 15 
included studies, 14 reported on the type of mechanism(s) examined and one did not. The type of
mechanisms examined in the 14 studies included elevated levels of estrogen and or progesterone,
biotransformation to acetaldehyde, formation of deoxyribonucleic acid (DNA) adducts, elevation of
serum prolactin, suppression of cellular immunity, enhancement of rate of tumor progression, and effect
on DNA synthesis. Administration and duration of ethanol exposure varied across all studies. Studies also
varied on whether a carcinogen was administered to induce carcinogenesis. Of the 15 studies, 10 reported 
the use of a carcinogen to induce cancer:
dimethylene (a) anthracene [DMBA] (five studies)
N-methyl-N-nitrosurea [MNU] (two studies)
N-nitrosodimethylamine [NMDA] and 4-methylnitrosoamino-1-3-pyridyl-1-butanone
[NNK] (one study)
MADB106 [one study]
bittner virus [one study]. 
Cell line studies. We included 15 studies using cell lines to evaluate the possible 
mechanisms for alcohol consumption and breast cancer risk. Twelve studies administered 
ethanol alone, and two studies administered ethanol combined with acetaldehyde. Cell lines 
examined in the studies included:
MCF-7 (six studies)
2
 
   
   
  
    
   
  
    
    
  
      
   
 
  
    
    
 
 
   
  
 
  
  
   
  
  
   
  
  
   
 
  
  
  
   
    
  
  
 
MCF-10F (two studies)
 
T4TD (one study)
 
MM46 tumor cells (one study)
 
MCF-7 + T47D (one study)
 
MCF-7 + T84 (one study)
 
MDA-MB-453 (one study)
 
MCF-7 + T47D + MDA-MB-231 (one study)
 
MCF-7 +ZR75.1 + BT-20 + MDA-MB-231 (one study). 

Various mechanisms were reported by these studies: hormonal-related, DNA-adduct 
formation, inflammation and cell death, cell differentiation, increase cyclic adenosine
monophosphate (cAMP), change in potassium channels, and modulation of gene expression.
Colorectal cancer studies.
Human study. We included one study using human tissues to evaluate the possible 
mechanism for alcohol consumption and colorectal cancer risk. The study exposed colonic
mucosa to acetaldehyde vapor. Although the study did not report direct evidence to show 
causation of cancer, the authors concluded that acetaldehyde may cause an increase in risk of 
colon cancer via loss of cell-cell adhesion.
Animal studies. We included 19 studies using animal models to evaluate the possible 
mechanisms for alcohol consumption and colorectal cancer risk. Outcomes varied across all
studies. Of the 19 included studies, 17 reported on the type of mechanism(s) examined and two 
did not. The type of mechanisms examined in the 17 studies included:
cytochrome system expression
generation of acetaldehyde
DNA methylation
effect of folate metabolism
cell proliferation
formation of acetaldehyde by human colonic bacteria
local mucosal effect
effect on various phases of carcinogenesis.
Administration and duration of ethanol exposure varied across all animal studies. Studies 
also varied on whether a carcinogen was administered to induce carcinogenesis. Of the 19 
studies, 12 reported the use of a carcinogen to induce cancer: 
1,1-dimethylhydrazine (DMH) (six studies)
methylazoxymethanol (MAM) acetate (one study)
acetoxymethyl-methylnitrosamine (AMMN) (one study)
AMMN + cyanamide (CY) (one study)
azoxymethane (AOM) (three studies). 
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Cell line studies. We included 10 studies using cell lines to evaluate the possible 
mechanisms for alcohol consumption and colorectal cancer risk. Cell lines examined in the 
studies included:
Caco-2 (six studies)
 
HT-29 (one study)
 
colonic mucosa cells (one study)
 
Caco-2 + HT-29 (one study)
 
HT-29 + SW-1116 + HCT-15 (one study). 

Various mechanisms were reported by these studies:
folate uptake modulation
tumor necrosis factor modulation
inflammation and cell death
formation of crosslinks with DNA
cell differentiation
modulation of gene expression.
Amount and duration of ethanol and/or acetaldehyde varied across all studies. Seven studies
administered ethanol alone, while three studies administered ethanol combined with 
acetaldehyde. 
Combination study (animal, cell line).We included one study that used a combination of
animal (mice) and cell line (Caco-2) to evaluate the possible mechanisms for alcohol 
consumption and colorectal cancer risk. Intestinal cell proliferation as a result of 
phosphatidylethanol accumulation was the examined mechanism. The animal study administered 
ethanol, and the cell line study administered either ethanol or acetaldehyde. The primary
outcome reported was disruption of cellular signals.
Discussion
The relationship between alcohol consumption and the risk of breast and colorectal cancers 
has been assessed in several systematic reviews and epidemiology studies (cohort and case-
control studies). In this report, we looked at the potential mechanism(s) connecting both breast 
and colorectal cancers with alcohol consumption, under the assumption that there is a causal 
relationship. Our report did not focus on such a causal relationship reported in epidemiology
literature where alcohol consumption was not under experimental control, but rather on potential 
mechanism(s) in studies that administered either alcohol or acetaldehyde in the absence of 
cancer. Only the human studies that actually administered ethanol regardless of experimental 
model were abstracted and included in the primary evidence base to assess possible 
mechanism(s). In addition, given that acetaldehyde is a metabolite of ethanol, we included 
animal studies that administered either alcohol and/or acetaldehyde in our evidence base. In 
humans, acetaldehyde levels in the blood are either very low or undetectable following alcohol 
consumption. Epidemiology studies that administered survey questionnaires to assess alcohol 
consumption and cancer risk and hypothesis-generating studies that examined potential pathways 
connecting alcohol to cancer risk were included as a separate evidence base.
The majority of the animal studies that chemically induced tumors through the administration 
of both alcohol and a carcinogen reported an increase in the carcinogenic effect; however, 
these studies can only offer indirect evidence of a connection between alcohol consumption and 
4
 
  
    
  
   
    
 
 
  
 
  
  
 
 
 
 
  
  
   
  
 
 
 
   
  
 
  
 
  
  
  
   
 
  
increased cancer risk in humans. Most of these studies varied in terms of quantity of ethanol and 
timing of administration relative to the carcinogen that was used in the study to induce
carcinogenesis. Though some of the possible mechanisms identified in this report have been 
evaluated in a variety of experimental models (i.e., human, animals, cell lines), others have
simply been examined as hypothesis generating and as such may call for future research.
Breast cancer. Both human and animal studies included in our primary evidence base point
to a connection between alcohol intake and changes in blood hormone levels, especially elevated 
levels of estrogen and androgens in humans. Several cell line studies also suggest that estrogen 
receptor pathways may be altered by ethanol. Increased estrogen levels may increase the risk of 
breast cancer through increases in cell proliferation and alterations in estrogen receptors. 
Elevation in prolactin levels were also examined in human and animal studies. While not as 
extensive as the estrogen-related studies, these studies give some indication that alcohol 
consumption may alter prolactin levels and increase the risk of developing breast cancer. In order 
to report the role of oxidative stress in breast cancer, one human study measured changes in the
levels of serum biomarkers.
The formation of acetaldehyde after ethanol consumption and its involvement in breast 
cancer has been examined in human epidemiology studies of enzyme polymorphism. 
Polymorphism in the enzymes that metabolize ethanol may increase an individual’s exposure to 
toxic metabolites such as acetaldehyde and influence cancer risk if acetaldehyde is involved in 
breast cancer development. In animal studies, conversion of ethanol to acetaldehyde in mammary
tissue has been reported to have a significant effect on the progression of tumor development. 
Events downstream from acetaldehyde are likely being altered by the presence of acetaldehyde
and may lead to enhanced tumor development.
Enhancement of cell proliferation and tumor progression related to ethanol consumption and 
conversion to acetaldehyde were examined in animal and cell line studies. The findings of these
studies suggest that alterations in cell proliferation due to alcohol exposure may be a possible 
mechanism increasing breast cancer risk.
Colorectal cancer. One human study reported that acetaldehyde disrupts epithelial tight 
junctions and cell adhesion. Several animal studies also looked at the effects of acetaldehyde in 
the colon and reported the following: mucosal damage after ethanol consumption, increased 
degradation of folate, stimulation of rectal carcinogenesis, and an increased effect of carcinogens 
in the presence of acetaldehyde. In cell line studies, acetaldehyde exposure was reported to 
influence the initial steps of colonic carcinogenesis and later tumor development and decrease
the activity of some brush border enzymes. Finally, a study using human tissue, animal tissue, 
and a cell line found evidence that acetaldehyde stimulates cell proliferation in intestinal crypt 
cells and therefore acetaldehyde may act as a cocarcinogen in the colon. These studies (human, 
animal, and cell line) combine to suggest that acetaldehyde production in the colon may provide 
a potential causal mechanism by which alcohol contributes to the development of colon cancer.
An effect of ethanol consumption on cell proliferation in the colon was investigated in a
combination study (animal and cell line). In this study, chronic alcohol exposure resulted in 
disruption of signals that normally restrict proliferation in highly confluent intestinal cells, 
thereby facilitating abnormal intestinal proliferation. Several animal studies reported enhanced 
growth of mucosal tissue after chronic ethanol consumption. Cell studies indicate that exposure
to ethanol and acetaldehyde increases cell proliferation and damages DNA which may contribute
to cancer development. Together these studies suggest that ethanol and acetaldehyde exposure in 
5
 
     
 
 
 
  
  
 
  
    
 
   
 
 
the colorectal mucosa may increase cell proliferation and be a potential mechanism connecting
alcohol consumption to colorectal cancer risk.
Conclusions
Based on our systematic review of the literature, many potential mechanisms by which 
alcohol may influence the development of breast or colorectal cancers have been explored but 
the exact connection or connections remain unclear. The evidence points in several directions but
the importance of any one mechanism is not apparent at this time. Several mechanisms have
been proposed and human, animal, and cell line studies have provided evidence in support of 
several mechanisms, but the findings have been inconsistent. The diversity of experimental 
protocols among the studies included in this report could have contributed to the lack of 
consistency. Furthermore, variation across included studies for both the route of administration 
and amount of ethanol may have influenced results. Based on animal studies alone, researchers 
may be inclined to infer a causal link between alcohol and the risk of breast or colorectal cancers. 
In addition, although a majority of the epidemiology studies reported that alcohol increased the 
risk of both breast and colorectal cancers, we cannot discount uncontrolled confounding by diet 
and related lifestyles.
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Chapter 1. Introduction
Scope
The purpose of this report is to systematically and objectively synthesize evidence from the 
basic science literature to clarify the possible causal mechanisms by which alcohol may
contribute to cancer risk, focusing on the induction and development of breast cancer and 
colorectal cancer under the assumption that there is a causal relationship. Therefore, the primary
evidence base for this report consists of studies that administer ethanol or acetaldehyde to 
humans, animals, tissues, or cells and then look for the development of breast or colorectal 
cancer, or for changes in metabolic pathways and cellular structures that may increase the risk 
for developing these cancers. Case-control and other epidemiology studies are not included in the 
primary evidence base for assessment of possible mechanisms. However, such studies may
provide insight into the dose/response relationship between alcohol consumption and cancer risk.
Apart from alcohol (i.e., ethanol) and water, the exact composition of most alcoholic 
beverages (e.g., beer, wine, or distilled spirits) on the market remains confidential proprietary
information.1 Therefore, the scope of this report is limited to ethanol. Other compounds (or
contaminants) found in various alcoholic beverages that may play a role in the development of 
breast and colorectal cancers are outside the scope of this report. These compounds include
nitrosamines, aflatoxins, polyphenols, ethyl carbamate (urethane), asbestos, and arsenic
compounds.1-4 
In addition, studies that evaluated tumor progression or metastatic spread of either breast or 
colorectal cancer during alcohol consumption are outside the scope of this report because they
are not examining the mechanisms underlying the association of alcohol and the risk of 
developing cancer.
Ethanol Metabolism
Orally-ingested ethanol from an alcoholic drink is rapidly and almost completely absorbed by
the stomach, small intestines, and colon. The bioavailability of ethanol, the fraction of the 
ingested dose that reaches the systemic circulation, is about 80%.5 Therefore a large portion of 
ingested ethanol reaches the circulation (i.e., blood alcohol concentration) and is distributed to all 
body tissues including the breast, colon, and rectum. Blood alcohol concentration, however, may
vary depending on the rate of gastric emptying and degree of metabolism during this first pass 
via the stomach and liver (i.e., first-pass metabolism of ethanol).6-8 
Ethanol is metabolized in the body by two pathways (i.e., oxidative and nonoxidative).8 
However, the nonoxidative pathway is minimal compared to the oxidative pathway.8 The liver 
is the major organ for the oxidative metabolism of ethanol.9,10 Ethanol is converted into 
acetaldehyde by cytosolic alcohol dehydrogenase (ADH).9-11 Due to variation in gene encoding
there are multiple isoenzymes of ADH that vary in their enzyme activity (ADH1A, ADH1B*1, 
2,3,9,11-17 ADH1B*2, ADH1B*3, ADH1C*1, ADH1C*2, ADH4, ADH5, ADH6, and ADH7).
The ADH1B*2 is lower in frequency amongst Caucasians and higher among Asians and is about 
40 times more active compared to the ADH1B*1 in the conversion of ethanol to acetaldehyde.18 
ADH1C*1 is very common in Asians, and metabolizes ethanol 2.5 times faster compared to 
18,19 ADH1C*2. Among individuals who consume alcohol, ADH1C*1, a fast-acting metabolizer 
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of ethanol, results in accumulation of acetaldehyde. As a result of increased levels of 
acetaldehyde, these individuals may experience uncomfortable side effects, and may well have a
18,19 tendency to consume less alcohol. The genetic polymorphism of ADH leads to differences in 
individual ethanol metabolism and individual differences in the susceptibility to alcohol-related 
tissue damage.8,18 
Acetaldehyde, a metabolite of ethanol, is further metabolized to acetate primarily by
mitochondrial aldehyde dehydrogenase (ALDH2).9,11 ALDH2 accounts for the greater part of 
acetaldehyde breakdown and exists as ALDH2*1 and ALDH2*2. Individuals with ALDH2*2 
have blood acetaldehyde levels 20 times higher compared to those with ALDH2*1.18 
Acetaldehyde is a highly toxic metabolite that binds to many cellular proteins and may be
responsible for damage in the liver as well as other body tissues.8 It binds to deoxyribonucleic
acid (DNA), resulting in the formation of a DNA adduct which may influence cancer 
development.3,11 Presence of a DNA adduct is a sign of exposure to specific cancer-causing
3,11,13 agent, and is indicative of growing damage to the DNA. Acetaldehyde is a cancer-causing
agent in animals.14 
During each oxidative process, nicotinamide adenine dinucleotide (NAD+) is reduced to 
NADH. In the liver, ethanol metabolism also involves microsomal cytochromes P450 2E1
(CYP2E1).11 This pathway produces reactive oxygen species (ROS) such as superoxide anions
2,8,11 and hydroxyl radicals which may increase the risk of tissue damage.
Nonoxidative metabolism of alcohol involves two pathways.8 One pathway results in the
formation of fatty acid ethyl esters and the other the formation of phosphatidyl ethanol.8,9 
ADH is present in the human colonic mucosa as well as in the microflora inhabiting the 
20,21 colon, and ethanol is metabolized to acetaldehyde by ADH in both of these locations.
ADH activity is significantly higher in the mucosa of the rectum than the colon.21 Aldehyde
dehydrogenase activity is much greater in the liver than in the colonic mucosa, which favors the
20 10accumulation of acetaldehyde in the colon. Breast tissue contains ADH and CYP2E1. Breast 
tissue converts ethanol to acetaldehyde which is then metabolized to acetate by xanthine
oxidoreductase.
Alcohol and Cancer
Fewer than 10% of cancers can be attributed to an inherited genetic abnormality.22 The
majority of cancers are the result of changes in the gene structure due to the loss of control 
mechanisms that prevent cancer development.22 Control mechanisms that may be altered during
cancer development are: 1) tumor suppressor genes that lose their function causing a disruption 
in cellular adhesion and abnormal cell cycle progression, 2) DNA repair enzymes that become 
nonfunctional due to distorted methylation, and 3) proto-oncogenes that mutate into oncogenes.22 
The course by which normal cells are transformed into cancer cells is termed carcinogenesis
(see Figure 1).3,14 When administered in combination with a recognized carcinogen, ethanol or
its metabolite (acetaldehyde) produces reactive oxygen species (ROS).10 ROS may increase the 
transformation of normal cells into cancerous cells in various organs by inhibition of DNA 
3,10,14,23,24 methylation as well as by interacting with metabolism of retinoids. Alcohol and its
metabolites have been implicated in all three stages of cancer formation (see the asterisks in
3,9,11,13,14,24,25Figure 1): 
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initiation stage by impact on DNA repair
promotion stage by altered gene expression, enhanced cell division, suppression of
immune response, and change in metabolism of vitamin A
progression stage by expression of oncogenes, exchange of DNA between chromosomes, 
and additional mutations.
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Figure 1. Three stages of carcinogenesis 
Microsomal enzymes
Normal cell
Damaged cell
Preinitiated cell
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Benign tumor cell
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Carcinogen
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*Source from http://www.niaaa.nih.gov/resources/graphicsgallery/immunesystem/lieb.htm26 
12
 
   
  
 
  
   
   
 
  
   
  
  
 
 
   
 
 
 
 
   
  
 
 
  
 
 
    
    
 
 
   
  
 
 
  
  
   
    
 
Alcohol consumption is highly prevalent in the general U.S. population. The 2008 prevalence
and trends data from the Behavioral Risk Factor Surveillance System indicate that about 54% of
U.S. adults consumed alcohol within the past 30 days.27 Though moderate alcohol consumption 
may have some potential health benefits, alcohol consumption has been identified as one of the
major worldwide risks for burden of disease.28 In the U.S., a standard drink is 12 fl oz (beer), 
29-32 8 fl oz of malt liquor, 5 fl oz (wine), and 1.5 fl oz (80% proof distilled spirit). Each is 
29-32 equivalent to 0.6 fluid ounces (12-14 g) of ethanol. Moderate daily alcohol consumption in 
29-32 the U.S. for men is two drinks and for women is one drink. However, variations have been 
reported worldwide in the definition of what is moderate for men and women.29 
Several epidemiology studies have reported moderate to strong associations between the 
level of alcohol consumption and the incidence of cancers of the mouth, pharynx, larynx, 
2,24,33-35 esophagus, and liver. Although the association between alcohol and breast and colorectal 
cancer is comparatively less strong than the association with these other cancers, given the high 
prevalence and incidence of breast and colorectal cancer, reducing the effect of any contributing
3,24,33,34,36-41 factor may have a large overall impact on cancer incidence and prevalence. Observed 
associations of alcohol consumption and cancer, however, can be confounded by other risk 
factors for cancer, such as age, smoking, family history, obesity and physical activity, race or 
14,36,42-44 ethnicity, and nutrition. Because of the high prevalence of alcohol consumption, 
exploring the potential underlying mechanism(s) of the association between alcohol consumption 
and breast and colorectal cancers, if any, is essential in developing primary preventive measures. 
In view of the fact that alcohol consumption is a modifiable behavior,45 recommending and 
promoting changes in behavior and appropriate preventive interventions may help reduce cancer 
risks in the general population.
Breast Cancer
According to the US National Cancer Institute (NCI), breast cancer is the most common 
cancer among women. 46 In 2009, it was anticipated that of the 192,370 women who were
diagnosed, 40,170 would die of breast cancer.46 Risk factors include family history, age at first 
birth, obesity in post menopausal women, dietary factors, alcohol consumption, early menarche, 
18,46 hormonal replacement therapy, low-dose irradiation, and lactation. Estrogen-induced breast 
cancer may result from cell proliferation, activation of cytochrome P450, and DNA damage.10 
Cell proliferation is significant in the maintenance of normal and healthy breast tissue and these
risk factors may alter cell proliferation in a direction that favors cancer development. 
Furthermore, enzyme polymorphism affects alcohol metabolism and could influence the effect of 
alcohol consumption on hormonal levels, thereby resulting in an increased risk of breast 
47-50 cancer. Among patients diagnosed with breast cancer, unregulated breast epithelial cell
growth has been reported.51 Alcohol consumption has been investigated as a risk factor in the
development of breast cancer. In a 2006 meta-analysis of 98 studies of alcohol and breast cancer, 
Key et al. reported that each additional 10 g ethanol/day resulted in a 10% increase in the odds 
ratio (OR) of risk of breast cancer associated with alcohol consumption.52 
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Colorectal Cancer
Of the estimated 75,590 men and 71,380 women diagnosed with colorectal cancer, 
49,920 men and women were expected to die of the disease in 2009.53 Among adults with
cancer, colorectal cancer is the second most common cause of death.54 Risk factors
13,14,53-58 include:
age
smoking
low fiber diet
high red meat/low fish intake
inadequate intake of folate, B6 and retinoids
obesity
lack of physical activity
low calcium intake
alcohol (heavy consumption)
an increase in colonic acetaldehyde level concentration
chronic ulcerative colitis
granulomatous colitis
adenomatous polyps
In addition, following alcohol consumption, intracolonic ethanol is metabolized by colonic
mucosal cells and intracolonic microbes. The risks of colorectal cancer development associated 
with alcohol consumption have been examined in epidemiology studies. In a 2004 meta-analysis
of eight studies, Cho et al. reported that daily consumption of more than 45 g of alcohol 
increased the risk of colorectal cancer by 45%.36 In addition, Homann et al. in a 2009 study
reported that individuals with ADH1C1*1 homozygosity and consumption of more than 30 g of 
alcohol per day have significant increase risk of colorectal cancer.19 
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Chapter 2. Methods
Technical Expert Panel
ECRI Institute, in consultation with AHRQ, recruited a technical expert panel (TEP) to give
input on key steps including the selection and refinement of the questions to be examined. Broad 
expertise and perspectives were sought. Divergent and conflicted opinions are common and 
perceived as healthy scientific discourse that results in a thoughtful, relevant systematic review. 
Therefore, in the end, study questions, design and/or methodologic approaches do not necessarily
represent the views of individual technical and content experts. The expert panel membership is 
provided in the front matter of this report.
ECRI Institute created a protocol for developing the evidence report. The process consisted 
of working with AHRQ and the TEP to outline the report’s objectives and to finalize Key
Questions for the review. These Key Questions are presented in the Scope and Key Questions 
section of the Introduction. Upon AHRQ approval, the draft protocol was posted on the AHRQ 
Web site at http://www.ahrq.gov/clinic/tp/alccantp.htm.
Peer Review and Public Commentary
A draft of the completed report was sent to the peer reviewers and the representatives of
AHRQ. In response to the comments of the peer reviewers, revisions were made to the evidence
report, and a summary of the comments and their disposition was submitted to AHRQ. Peer 
reviewer comments on a preliminary draft of this report were considered by the EPC in 
preparation of this final report. Synthesis of the scientific literature presented here does not
necessarily represent the views of individual reviewers.
Key Questions
The purpose of our assessment of the basic science literature concerning alcohol and cancer 
induction is not to determine the extent to which alcohol is a risk factor for breast and colorectal 
cancers, but instead to explore the evidence suggesting possible underlying causal mechanism(s)
of the association between alcohol consumption and breast and colorectal cancers (see broken 
arrows from alcohol to cancer induction in Figure 2 and Figure 3). Therefore, we developed four
Key Questions that address the potential mechanism(s) by which alcohol might be involved in 
the development of breast and colorectal cancers.
Key Question 1. What are the likely causal mechanisms by which alcohol contributes to the
development of breast cancer? Which of the possible mechanisms (e.g., induction of P450
cytochromes and carcinogen metabolism, effects on blood hormone concentrations, effect of
acetaldehyde or other alcohol metabolite on apoptosis and DNA repair, interactive effects on 
other nutritional factors, or others) are likely to be most important in breast cancer 
development?
Key Question 2. For the most likely mechanisms of action involving alcohol and the 
development of breast cancer, how might other factors modify the effect of alcohol on breast 
cancer (for example, age, latency of effect, intensity, duration, and recency of exposure, presence
of co-carcinogens, presence of threshold effect)? Do the causal mechanisms vary by cell type or 
other tumor characteristics?
15
 
Key Question 3. What are the likely causal mechanisms by which alcohol contributes to the 
development of colorectal cancer? Which of the possible mechanisms (e.g., induction of P450 
cytochromes and carcinogen metabolism, effects on blood hormone concentrations, effect of 
acetaldehyde or other alcohol metabolite on apoptosis and DNA repair, interactive effects on 
other nutritional factors, or others) are likely to be most important in colorectal cancer 
development? 
Key Question 4. For the most likely mechanisms of action involving alcohol and the 
development of colorectal cancer, how might other factors modify the effect of alcohol on 
colorectal cancer (for example, age, latency of effect, intensity, duration, and recency of 
exposure, presence of co-carcinogens, presence of threshold effect)? Do the causal mechanisms 
vary by cell type or other tumor characteristics? 
Analytical Framework 
Figure 2 for breast and Figure 3 colorectal cancer portray analytical framework that visually 
describe the potential links in a chain of evidence that connect alcohol to breast and colorectal 
cancers. Contained within the framework are the Key Questions being addressed by this report 
and the potential areas of study (humans, animals, tissues, cells, ethanol and its metabolites) that 
can be manipulated to examine the assumed connection between alcohol consumption and an 
increased risk of developing breast or colorectal cancer. 
Figure 2. Analytical framework for breast cancer 
Human or Animal 
Isolated Organs and 
Cells Alcohol
Alcohol 
metabolites
Other risk 
factors
Cancer induction, 
promotion or 
progression
Whole 
Human or 
Whole 
Animal
Cell lines
Breast 
Cancer
KQ 1 
KQ 2 
KQ: Key Question
KQ 1: effect of alcohol on stages of carcinogenesis 
KQ 2: effect of alcohol and other risk factors on stages of carcinogenesis 
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Figure 3. Analytical framework for colorectal cancer 
Human or Animal 
Isolated Organs and 
Cells Alcohol
Alcohol 
metabolites
Other risk 
factors
Cancer induction, 
promotion or 
progression
Whole 
Human or 
Whole 
Animal
Cell lines
KQ 3 
KQ 4 
KQ: Key Question
Colorectal 
Cancer
KQ 3: effect of alcohol on stages of carcinogenesis 
KQ 4: effect of alcohol and other risk factors on stages of carcinogenesis 
Identification of Clinical Studies 
The studies included in the primary evidence base for this technology assessment were 
identified using a multi-staged study selection process, and were based on inclusion criteria that 
were determined a priori, after the creation of the Key Questions and before any detailed 
examination of the literature base. Use of a priori inclusion criteria reduces the risk of bias 
because the decision to include or exclude each study is independent of the results of the study. 
In the first stage of the selection process, we performed a comprehensive literature search using 
broad criteria. In the second stage, we retrieved all articles that appeared to meet the a priori 
inclusion criteria, based on their published abstracts. In the final stage of the study selection, we 
reviewed the full text of each retrieved article, assessed its internal validity, and verified whether 
or not it met the a priori inclusion criteria. 
Electronic Database Searches 
We searched 11 external databases, including PubMed and EMBASE, for studies on possible 
mechanisms of alcohol and breast and colorectal cancer development (i.e., initiation, promotion, 
and progression) to identify evidence relevant to the Key Questions 1-4 using Medical Subject 
Headings and free text words. Additionally, we used some of the search terms and sources that 
were suggested by the Technical Expert Panel members on October 28, 2009. Two reviewers in 
the investigative team independently screened search results, selected studies to be included and 
reviewed each trial for inclusion. To supplement the electronic searches, we manually examined 
the bibliographies of included studies, scanned the content of new issues of selected journals, and 
reviewed relevant gray literature for potential additional articles. Gray literature includes reports 
and studies produced by local government agencies, private organizations, educational facilities, 
and corporations that do not appear in the peer-reviewed literature. Although we examined gray 
literature sources to identify relevant information, we only consider published, peer-reviewed 
literature in this report. During the peer review process, any new studies or data recommended 
17
 
   
 
 
 
 
 
 
   
   
 
  
 
 
 
  
   
   
   
 
  
 
 
 
 
 
   
 
 
    
      
     
  
 
were subjected to the same inclusion and exclusion criteria. A complete list of the databases 
searched and the search strategy used to identify relevant studies are presented in Appendix A.
Study Selection
Use of explicit inclusion criteria, decided upon before any data have been extracted from 
studies, is a vital tool in preventing reviewer biases. Some of the a priori criteria are based on 
study design, and other criteria ensure that the evidence is not derived from unusual patients or 
interventions, and/or outmoded technologies. We developed the same inclusion criteria for each 
Key Question that this report addresses.
Criteria for Inclusion/Exclusion of Studies in the Review
We used the following formal criteria to determine which studies were included in the 
primary evidence base that addresses each Key Question. These studies are primarily
experimental studies where the exposure to ethanol or acetaldehyde could be controlled and 
precise biochemical measurements could be made.
1.	 Any study, regardless of design, that provides data on the possible causal mechanism(s)
of any association between alcohol consumption and the development of breast and 
colorectal cancers in any population setting, including humans, animals, and in vitro 
experimental studies.
2.	 In order to assess the outcome measure of carcinogenesis, there must be no breast or 
colorectal cancer present in human and animal studies prior to the start of the study.
3.	 Cell lines should be appropriate to the study of breast and colorectal cancers in humans.
4.	 Studies that report on metastatic lesions or tumor invasion were excluded because they
do not discuss the likely causal mechanism(s) of the tumor at the primary site (breast or 
colorectal).
5.	 When the same study was published more than once, we used the data from the most
recent publication. However, if the older report had provided data that was not provided 
by the most recent report, we included such data.
6.	 Studies must have administered ethanol. Studies that administered alcoholic beverages 
such as beer or malt liquor were excluded given that the exact composition of such drinks 
remains confidential.
Studies that did not specifically control alcohol exposure were also considered in this report 
but were not included in the primary evidence base addressing the Key Questions. Hypothesis-
generating studies examining metabolic pathways that may connect alcohol to cancer risk and 
epidemiology studies of alcohol exposure (including those in patients with or without cancer)
were incorporated into the report in order to review and discuss this literature for comparison 
with our primary evidence base from experimental studies.
Literature Review Procedures
The abstracts for all identified documents were downloaded into the Mobius Analytics SRS
4.0 Web-based system for conducting systematic reviews. Using this system, we assessed 
abstracts in order to either include or exclude identified documents based on our inclusion 
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criteria. If the abstract was missing or had insufficient information to make a decision on 
inclusion we ordered the full article. Full articles were then retrieved for review and 
categorization using Web-based forms. The Web-based system provided a structured framework 
to build and manage the numerous documents identified by our searches.
The review process underwent four levels:
Level 1 – Abstract Review
Level 2 – Full Document Review
Level 3 – Background Document Review
Level 4 – Evidence Base Document Review. 
Each level has an electronic form for capturing data about each document identified in our 
searches (see Appendix B for sample data abstraction forms).
Data Abstraction and Data Management
All documents that were identified as belonging in the evidence base of the report underwent 
data abstraction using EXCEL spreadsheets. Table B-1 in Appendix B provides a list of the data 
abstracted from each study and placed in to a separate column in the spreadsheet. Some of the 
columns were modified depending on whether a study examined humans, animals, or cell lines. 
The information in the spreadsheets was later used to create the evidence tables in this report.
Disposition of the Documents Identified by Literature Searches
The SRS Web-based system allowed us to track all identified documents along with their 
complete citation. Literature searches were updated periodically and the new documents were
added to the system and reviewed. Using the information contained in the SRS database we were
able to create Figure 4 to illustrate an attrition diagram as well as separate tables that show the
disposition of the documents identified by our literature searches. A total of 819 documents were
identified by our searches. After review of the abstracts and then full documents, we included 
264 documents for discussion within the report. Of these 264 documents, 66 met the 
requirements for the primary evidence base because they addressed one of the Key Questions. 
An additional 197 documents were included because they addressed issues related to alcohol and 
breast or colorectal cancer risk.
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Figure 4. Disposition of the documents identified by literature searches 
66 Studies addressing the Key Questions, this constitutes the     
primary evidence base of the report:
        6 Human studies (5 breast cancer, 1 colorectal cancer)
       34 Animal exposure  (15 breast cancer, 19 colorectal cancer)
       25 Human cell lines  (15 breast cancer, 10 colorectal cancer)
         1 Combination [animal/cell line] on colorectal cancer
Abstracts 
screened
359 Documents 
excluded at the 
abstract level
 460 Full documents 
retrieved
Full 
documents 
reviewed
264 documents to be 
included in the report
819 Documents 
identified
196 Documents 
excluded at the full 
document level
Full documents 
for inclusion in the 
evidence base
198 Documents that examined 
alcohol and cancer risk but did not 
specifically address the key 
questions:
14 Systematic reviews
(8 breast cancer, 6 colorectal cancer)
165 Epidemiology studies of alcohol   
and cancer
(47 breast cancer, 118 colorectal 
cancer) 
19 Hypothesis generating studies
(8 breast cancer, 11 colorectal cancer)
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Assessing the Evidence for Each Key Question
 
Assessment of Internal and External Validity
A critical part in the process of creating a systematic review is assessing the validity of the
results reported in each included study in the review. The validity of individual study results is
determined in the context of the Key Questions these studies address. Internal validity is the
extent to which a study’s design and conduct are likely to have prevented bias and produced 
results that describe a true relationship.59 
The members of the Technical Expert Panel proposed several methods for evaluating the 
internal validity of studies using animals, tissues, or cells as the primary experimental model.
Evidence from experimental studies offer the most compelling evidence that a 
mechanism/pathway is directly involved in increasing cancer risk with alcohol intake.
Use of alcohol concentration levels in animal studies that far exceed levels that occur
in humans are considered of low applicability.
Cell lines should be appropriate to the study of breast and colorectal cancer in 
humans.
To ultimately establish the presence of a contributory cause between alcohol consumption 
and breast or colorectal cancer, the following criteria have to be fulfilled: association, exposure
14,60-63 prior to the association, and demonstration that changing the cause alters the effect.
Other supportive criteria such as strength of association, consistency of association, biological 
60-63 plausibility, and a dose-response relationship can be used to establish contributory cause.
For this systematic review, we applied the “direct” vs. “indirect” evidence concept.64 Direct 
assessment measures are those which provide direct evidence that alcohol causes either breast or 
colorectal cancer. Such evidence as shown in Figure 1 may confirm the steps during cancer 
formation and possible sites of action of alcohol thus demonstrating a contributory cause.
Indirect measures typically focus on predictors that are correlated to carcinogenesis, but 
do not measure actual causation. Some of the most common indirect assessment measures 
3,10,13,14,18,41,55,65-81 include:
increased androgen and estrogen concentration
inactivation of the BRCA1 gene
formation of new capillaries (angiogenesis)
depletion of s-adenosylmethionine (SAM)
low iron levels, low folate and vitamin B12 levels
induction of epidermal growth factor
increase in tumor necrosis factor-alpha receptor
acetaldehyde formation by colonic bacteria
induction of CYP2E1
impairment of retinoic acid
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generation of reactive oxygen species and reactive nitrogen species
immune suppression (effects on peripheral T- and B-lymphocytes)
increase in cell membrane permeability
interference with DNA repair (acetaldehyde-DNA adducts)
increased levels of biomarkers of oxidative stress.
Because of the focus on the how and why of causation of cancer, indirect measures are
critical in our efforts to improve the evidence of direct causation in ongoing and future research 
of possible causal mechanisms explaining the increased risk of breast and colorectal cancer with 
alcohol consumption.
For this report, experimental studies that show direct evidence were treated as stronger 
evidence than studies of association which only showed indirect evidence. The strength of 
evidence supporting each proposed mechanism relating alcohol intake to the development of 
breast or colorectal cancer were categorized as either “Sufficient” or ”Insufficient.” Three
domains were evaluated: the potential risk of bias, or “internal validity” of the evidence base, the
size of the evidence base (number of studies examining any one proposed mechanism), and the
consistency of the findings (agreement across studies examining the same proposed mechanism).
External validity is the extent to which the findings and conclusions from a study or report 
can be translated to a specific setting or population (i.e., generalizability).59 Generalizability is 
always strongest when results are collected in the specific setting or population of interest.
However, clinical studies often cannot be conducted in such a setting or population, and results 
are instead collected from a more rigidly defined and less generalizable patient population. 
Human studies have more external validity than animal or cell line studies.
Data Synthesis
No meta-analyses were planned for this report. Given that this systematic review is 
hypothesis-summarizing and generating, we present a narrative summary of the findings based 
on the number of different mechanisms proposed and the studies showing support or lack of 
support for each mechanism.
Assessment of Internal Validity of Breast and Colorectal 
Studies
Internal validity, especially in the context of clinical studies, is the extent to which a study’s 
59,82 design and conduct are likely to have prevented bias. However, in the context of this report, 
which is assessing the results of human, animal and in vitro studies, we defined internal validity
as the extent to which a direct relationship can be seen between the result of a given study and an 
increase in the risk of developing breast or colorectal cancer following ethanol consumption. 
Although we believe that the included studies are valid in design and outcomes measured for
their intended purpose, we needed a measure of internal validity that was relevant to the 
connection between study results and cancer risk in humans. Therefore we considered human 
studies that administered alcohol having a higher internal validity than animal or in vitro studies. 
Animal studies that administered alcohol and did not use any known co-carcinogen were
considered as having a higher internal validity (more direct relationship to an increase in cancer 
risk) than studies that administered a carcinogen. Studies that administered acetaldehyde or 
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known carcinogens were considered as having lower internal validity and a less direct 
relationship with an increase in cancer risk in humans who consume alcohol.
Assessment of External Validity of Breast and Colorectal 
Studies
In our report we did not identify any studies using human subjects that directly assessed the
possible mechanism(s) associated with risk of breast cancer following alcohol consumption. 
However, we did identify one human study that indirectly reported on colorectal cancer risk 
association with alcohol consumption: exposure of colonic biopsy tissues to acetaldehyde.83 
For the animal studies, generalizability may be compromised by administering ethanol 
concentrations that far exceed levels suitable for human consumption, by administering
73,82,84 acetaldehyde, and by co-administering a known carcinogen. Therefore, the results of these
studies may not be directly applicable to human settings.
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Chapter 3. Results
Evidence Base Describing Possible Mechanisms Connecting
Alcohol Consumption and Breast Cancer Risk
Human Studies
We included five studies (see Table C-1 in Appendix C) that evaluated the possible
mechanisms connecting alcohol consumption and breast cancer risk: the first study examined 
effects of alcohol on estradiol, estrone, estrone sulfate, testosterone, androstenedione, 
progesterone, dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and androstenediol;85 
the second study86 examined the effects of alcohol on plasma and urinary hormone 
concentrations in premenopausal women; the third study87 examined the effect of alcohol on 
prolactin levels in menopausal women using estradiol replacement; the fourth study88 examined 
the effects of alcohol on estrogen levels in postmenopausal women; and the fifth study76 
examined the relationship of alcohol consumption with antioxidant nutrients and a biomarker of
oxidative stress. Although none of these five studies reported direct evidence of cancer, we
included them because alcohol was administered to examine alterations in hormonal 
mechanism(s) and biomarkers of oxidative stress that have been suggested to be linked to the
87-90 development of breast cancer. Four studies reported increased serum hormonal levels and 
one study76 reported an increase in isoprostane levels, a biomarker of oxidative stress. Table C-1
in Appendix C provides a summary of study design, mechanisms examined, amount and duration 
of ethanol or acetaldehyde exposure, study results, and authors’ conclusions.
In the study by Dorgan et al., 51 healthy postmenopausal women consumed 15 or 30 grams 
of alcohol per day or an alcohol-free placebo beverage through three 8-week dietary periods. 
Each dietary period was preceded by a 2- to 5-week washout period when participants did not 
consume any alcohol. The results showed an increase in serum levels of both estrone sulfate and 
DHEAS. While this study did not report any direct evidence to show causation of cancer, Dorgan 
et al. concluded that results suggest a possible mechanism by which consumption of one or two 
alcoholic drinks per day by postmenopausal women could increase their risk of breast cancer.85 
In the second study Reichman et al. examined 34 premenopausal women who consumed 30 g of 
ethanol daily for three menstrual cycles and no alcohol during three other cycles.86 The results 
showed an increase in plasma DHEA sulfate, plasma estrone, plasma estradiol, and urinary
estradiol. Reichman et al. concluded that these results suggest a possible mechanism between 
alcohol consumption and risk of breast cancer again because of changes in hormone levels.86 
In the third study, Ginsburg et al.87 conducted two randomized, crossover studies in post 
menopausal women: study 1 administered ethanol (1 mL/kg, 95% ethanol) vs. isocaloric drink; 
study 2 was similar to study 1 except authors removed transdermal estradiol patches after 
administration of either ethanol or isocaloric drink. In both crossover studies, Ginsburg et al.87 
reported an increase in serum prolactin levels. In the fourth study Ginsburg et al.88 administered 
ethanol (pineapple juice and 40% ethanol at a dose of 2.2 mL/kg of body weight [0.7 g/kg of 
body weight] in a total volume of 300 mL) vs. placebo to 24 postmenopausal women and 
reported a 3-fold increase in circulating estradiol levels in women on estrogen replacement 
therapy (ERT). In the fifth study Hartman et al.76 administered a controlled diet plus each of 
three treatments (15 or 30 g alcohol/day or no-alcohol placebo beverage) to 53 postmenopausal 
women, during three 8-week periods in random order and reported that moderate alcohol 
consumption increased isoprostane, a biomarker of oxidative stress by 4.9%.
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Animal Studies
We included 15 studies using animal models to evaluate possible mechanisms connecting
alcohol consumption with breast cancer risk (see Table C-2 in Appendix C). Of the 15 included
studies, 14 reported on the mechanism(s) and one91 did not. The mechanisms examined in the 
14 studies were:
92-94 elevated levels of estrogen and or progesterone
biotransformation to acetaldehyde95 
formation of DNA adducts96 
97,98 elevation of serum prolactin
suppression of cellular immunity99 
100-103 enhancement of rate of tumor progression
104,105 effect on DNA synthesis
Administration and duration of ethanol exposure varied across studies. Studies also varied on 
whether a carcinogen was co-administered to induce carcinogenesis. Of the 15 studies, 
10 reported the use of a known carcinogen to induce cancer: 
dimethylene (a) anthracene [DMBA] (five studies)
N-methyl-N-nitrosurea [MNU] (two studies)
N-nitrosodimethylamine [NMDA] and 4-methylnitrosoamino-1-3-pyridyl-1-butanone
[NNK] (one study)
MADB106 [one study]
bittner virus [one study].
Table C-2 in Appendix C provides a summary of mechanisms examined, amount and 
duration of ethanol or acetaldehyde exposure, carcinogen use, study results, and authors’
conclusions.
Outcomes measured varied across studies. Overall, six studies reported increased cancer 
92,93,103 91,97formation (four studies co-administered a carcinogen and two studies did not ).
The reported results of intermediate outcomes included:
biotransformation of ethanol to acetaldehyde95 
increase in the formation of DNA adducts96 
94,104,105 increase in terminal-end bud density and a decrease in alveolar bud structures
a reduction in blood natural killer cytotoxicity99 
Three studies reported no changes in outcomes and concluded that their findings did not 
100-102 support a link between alcohol consumption and the risk of breast cancer.
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Cell Line Studies
We included 15 studies using cell lines to evaluate possible mechanisms connecting alcohol 
consumption with breast cancer risk (see Table C-3 in Appendix C). Cell lines examined in the
studies included:
MCF-7 (six studies)
MCF-10F (two studies)
T4TD (one study)
MM46 tumor cells (one study)
MDA-MB-453 (one study)
MCF-7 + T47D (one study)
MCF-7 + T84 (one study)
MCF-7 + T47D + MDA-MB-231 (one study)
MCF-7 + ZR75.1 + BT-20 + MDA-MB-231 (one study). 
Various types of mechanism were reported by these studies: 
65,67-69,106 hormonal-related
107,108 DNA adduct formation
51,109,110 effect on cell proliferation
increase cAMP111 
change in potassium channels112 
mammary gland mucin upregulation113 
smooth muscle up-regulation during transcription114 
Amount and duration of ethanol and/or acetaldehyde exposure varied across all studies.
Ten studies administered ethanol alone, and two studies administered ethanol combined with 
acetaldehyde. Table C-3 in Appendix C provides a summary of mechanisms examined, amount
and duration of ethanol or acetaldehyde exposure, study results, and authors’ conclusions.
68,106,113,115 Five studies reported an increase in the expression of mRNA, two studies reported 
107,108 an increase in the formation of DNA adducts, two studies reported an increase in cell
65,69 3 51,110 proliferation, two studies reported enhancement of H-thymidine uptake, one study
114 109reported up-regulation of smooth muscle myosin alkali light chain, and one study reported 
reduction in the expression ribosomal protein L7a.
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Evidence Base for Describing Possible Mechanisms 

Connecting Alcohol Consumption and Colorectal Cancer
 
Risk
 
Human Studies
We included one study (see Table C-4 in Appendix C) using human tissues to evaluate the
possible mechanism connecting alcohol consumption with colorectal cancer risk. The study
exposed colonic mucosa to acetaldehyde vapor.83 Although no direct evidence to show a 
connection between acetaldehyde exposure and cancer risk was reported, the authors concluded 
that acetaldehyde may cause an increase in risk of colon cancer via loss of cell-cell adhesion.83 
Table C-4 in Appendix C provides a summary of study design, mechanisms examined, amount
and duration of acetaldehyde exposure, study results, and authors’ conclusions.
Animal Studies
We included 19 studies using animal models to evaluate the possible mechanisms for alcohol 
consumption and colorectal cancer risk (see Table C-5 in Appendix C). Of the 19 included 
116,117 studies, 17 reported on the mechanism(s) examined and two did not. The mechanisms 
examined in the 17 studies included: 
118,119 cytochrome system expression
70,120-123 generation of acetaldehyde
DNA methylation124 
125-127 cell proliferation
128,129 local mucosal effect
73,130,131 effect on various phases of carcinogenesis
Administration and duration of ethanol exposure varied across all studies. Studies also varied 
on whether a carcinogen was co-administered. Of the 19 studies, 12 reported the use of a known 
carcinogen to induce cancer: 
1,1-dimethylhydrazine (DMH) (six studies)
methylazoxymethanol (MAM) acetate (one study)
acetoxymethyl-methylnitrosamine (AMMN) (one study)
AMMN + cyanamide (CY) (one study)
azoxymethane (AOM) (three studies).
Table C-5 in Appendix C provides a summary of mechanisms examined, amount and 
duration of ethanol or acetaldehyde exposure, carcinogen use, study results, and authors’
conclusions.
Outcomes measured varied across studies. Among the studies that co-administered a
73,123,126,128,129,132 131carcinogen, six reported increased cancer formation, one reported suppression 
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116,117 of cancer formation, and two reported no effect. Another study that did not co-administer a 
carcinogen reported an increase in cancer formation.121 The reported results of intermediate 
outcomes include:
118,122,125,127 increase in the number of aberrant crypt foci
increase in microsomal ethanol-oxidizing system activity120 
increase in acetaldehyde level resulting in folate degradation70 
undermethylation of DNA124 
increase in the expression of CYP2E1119 
decrease in the formation of DNA adducts130 
Cell Line Studies
We included 10 studies using cell lines to evaluate possible mechanisms connecting alcohol 
consumption with colorectal cancer risk (see Table C-6 in Appendix C). Cell lines examined in 
the studies included:
Caco-2 (six studies)
HT-29 (one study)
colonic mucosa cells (one study)
Caco-2 + HT-29 (one study)
HT-29 + SW-1116 + HCT-15 (one study). 
Various mechanisms were reported by these studies: 
folate uptake modulation133 
75,133 tumor necrosis factor modulation
inflammation and cell death134 
formation of crosslinks with DNA135 
136,137 initiation of cancer
cell differentiation138 
modulation of gene expression139 
Amount and duration of ethanol and/or acetaldehyde varied across all studies (seven studies
administered ethanol alone, three studies administered ethanol combined with acetaldehyde).
Table C-6 in Appendix C provides a summary of mechanisms examined, amount and duration of
ethanol or acetaldehyde exposure, study results, and authors’ conclusions.
Outcomes varied across all studies. Reported results included:
inhibitory effect on both 3H-folic and 3H-methotrexate uptake140 
increase in tumor necrosis factor-alpha receptor-175 
inflammation resulting in increased phosphatidylserine production134 
increase in mRNA expression74 
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dual effect on cell proliferation (acute acetaldehyde exposure inhibitory and chronic 
acetaldehyde exposure stimulating)136 
137,138 increase in sucrase and maltase activity
increase in alkaline phosphatase and sucrose activities, limited cytotoxicity133 
damage to DNA strands135 
lack of effect on the expression of HLA class 1 antigens139 
Combination Study (Animal, Cell Line)
We included one study141 that used a combination of animal (mice) and cell line (Caco-2) to 
evaluate the possible mechanisms connecting alcohol consumption with colorectal cancer risk 
(see Table C-7 in Appendix C). Intestinal cell proliferation as a result of phosphatidylethanol
accumulation was the examined mechanism. The animal study administered ethanol and the cell
line study administered either ethanol or acetaldehyde. Outcome reported was disruption of 
cellular signals. Chronic alcohol exposure resulted in an increase of maximal intestinal 
density.141
Systematic Reviews and Narrative Reviews of 

Epidemiology Studies
 
We identified and summarized the reported results and conclusions from 13 systematic reviews 
of epidemiology studies looking for an association between alcohol intake and cancer risk (seven
on breast cancer [see Table 1], six on colorectal cancer [see Table 2]). While these studies were not
considered part of our primary evidence base addressing the key questions of this report, they do 
provide important evidence connecting alcohol intake with breast and colorectal cancer risk in 
humans and provide a context for discussing the findings of the studies included in our primary
evidence base. The tables provide the review objectives, the resources searched, inclusion criteria, 
a summary of results, and the authors’ conclusions. Key areas examined by the systematic reviews 
of breast cancer included:
alterations in estrogen-dependent pathways
polymorphisms in one-carbon metabolism pathways
interaction with dietary folate intake
dose-response relationships between alcohol intake and cancer risk.
Key areas examined by the systematic reviews of colorectal cancer include differences in 
Japanese versus western populations, and amount of alcohol intake and cancer risk.
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Table 1. Systematic reviews/meta-analyses for breast cancer epidemiology studies
Conclusions
Resources Searched and as Reported by
 
Study
 Objective ResultsInclusion Criteria Study Authors
Suzuki et al. To quantitatively assess Eligible studies were The risk of developing breast Estrogen-dependent 
142
2008 the accumulated evidence identified by searching the cancer was statistically significant pathway alone cannot 
on the association between MEDLINE database from comparing the highest vs. lowest account for the 
alcohol intake and the risk January 1, 1970 through consumption categories for detected positive
of estrogen receptor (ER) April 20, 2007 for relevant developing: associations with 
and progesterone receptor epidemiology studies of alcohol for ER+PR+ER+ tumors 27% (1.17-1.38),
(PR)– defined breast alcohol consumption in and ER-PR+ tumors.all ER- tumors 14% (1.03-1.26), 
cancer subtypes and to relation to the risk of breast ER+PR+ tumors 22% (1.11-1.34), 
evaluate whether the cancer defined by ER/PR ER+PR- tumors 28% (1.07-1.53), 
observed association without any language but not ER-PR- tumors.
differs across ER/PR restriction.
An increase in alcoholstatus. Evidence base: consumption of 10 g of ethanol
Nineteen studies per day was associated with 
(4 prospective cohort studies statistically significant increased 
and 16 case-control studies) risks for:
all ER+ 12% (8%-15%),
all ER- 7% (0%-14%),
ER+PR+ 11% (7%-14%) and
ER+PR- 15% (2%-30%), 
but not ER-PR-.
Lissowska et al. To examine the role of Epidemiology studies of There was no significant Study did not support 
143
2007 genetic polymorphisms in methylenetetrahydrofolate association of breast cancer risk association between
the one-carbon metabolism gene (MTHFR A222V and with nutrients involved in one polymorphisms in the
pathway and breast cancer E429A) polymorphisms and carbon metabolism (i.e., folate, one-carbon
risk. breast cancer risk published vitamins B2, B6, B12, methionine) metabolism pathway
through August 2006 were or with alcohol intake. and the risk of breast 
identified through a PubMed cancer.
search.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Lewis et al. To summarize the available MEDLINE and ISI Web of Only two studies used the same There is no
2006
144 
evidence from observational knowledge databases for cut off points for alcohol intake. association between a 
studies on this issue and a relevant studies that were Therefore, evidence for interaction lack of dietary folate
meta-analysis of the published through between alcohol and folate intakes intake and breast 
association between a May 31, 2006. with respect to risk of breast cancer risk.
common polymorphism in Evidence base: cancer was inconclusive.
the 5,10-methylenetetra-
hydrofolate reductase 19 studies (13 case-control
(MTHFR) gene. studies and 9 cohort studies)
of which seven cohort 
studies and one case-control
study examined the 
interaction between alcohol
and folate intakes with 
respect to risk of breast 
cancer.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Key et al.
2006
52 
To give an up-to-date
assessment of the 
MEDLINE, EMBASE, 
Pascal (BIDS), Science 
association of alcohol with Citation Index (BIDS), 
female breast cancer, Social Sciences Citation
addressing methodological Index (BIDS), Index to
issues and shortfalls in Scientific and Technical
previous overviews. Proceedings (via BIDS), 
Biological Abstracts
(BIOSIS), Biological
Sciences, AIDS and Cancer
Research Abstracts, 
Biology Digest, Conference
Papers Index, Cochrane 
Library, NHS National
Research Register (NRR), 
SIGLE (System for 
Information on Grey
Literature), NTIS (National
Technical Information
Service), TOXLINE.
Evidence base:
98 studies (75,728 drinkers
vs. 60,653 non-drinkers)
Excess risk associated with alcohol Association between
consumption was 22% (9%-37%).
Each additional 10 g ethanol per 
day increases breast cancer risk
by 10% (5%-15%).
alcohol and breast 
cancer may be causal.
Estimated population attributable 
risk in the U.S.A. and U.K. were, 
1.6% and 6.0%, respectively.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Hamajima et al. A collaborative reanalysis Resources searched were The average consumption of Caution is needed to 
2002
34 
of individual data from not reported by study alcohol reported by controls from interpret the effect of
53 epidemiology studies, authors. developed countries was 6.0 g per alcohol on risk of
including 58,515 women Evidence base: day, i.e., about half a unit/drink of breast cancer.
with breast cancer and alcohol per day; greater in ever-
95,067 women without the 53 studies (51 published, smokers than never-smokers, 
disease. 2 unpublished) (8.4 g per day and 5.0 g per day,
respectively).
Compared with women who 
reported no alcohol, relative risk
(RR) of breast cancer was
1.32 (1.19-1.45, p <0.00001) for an 
intake of 35-44 g per day alcohol, 
and 1.46 (1.33-1.61, p <0.00001) 
for ≥45 g per day alcohol.
For each additional 10 g per day
intake of alcohol, the relative risk of
breast cancer increased by 7.1%
(5.5%-8.7%, p <0.00001).
Corrao et al.
145
1999
To compare the strength of
the evidence provided by the 
epidemiology literature on
the association between
alcohol consumption and
the risk of six cancers
(oral cavity, esophagus, 
colorectum, liver, larynx, 
breast).
MEDLINE from 1966 up to
and including 1998, 
articles reported by other
bibliographic databases
available at the University of
Miami (Current Contents
from 1996, EMBASE from
1980, CAB abstracts from
1973, and Core Biomedical
Collection from 1993).
Evidence base:
200 epidemiology studies
(29 breast).
RR for dose of alcohol intake for 
breast cancer in the Mediterranean
region* were:
1.6 (1.6-1.7) for 25 g per day,
2.7 (2.4-2.9) for 50 g per day, and
7.1 (5.8-18.6) for 100 g per day.
RR for dose of alcohol intake in 
other areas* were:
1.2 (1.1-1.3) for 25 g per day,
1.5 (1.2-1.8) for 50 g per day, and
2.1 (1.4-3.1) for 100 g per day.
*strata by region
Based on weak dose-
response relationship,
there is need for 
well-conducted
epidemiology studies.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Smith-Warner et al. To assess the risk of
1998
39 
invasive breast cancer 
associated with total and 
beverage-specific alcohol
consumption and to evaluate 
whether dietary and
nondietary factors modify the
association.
Resources searched were
not reported by study
authors.
Evidence base:
6 prospective studies that 
had at least 200 incident 
breast cancer cases, 
assessed long-term intake of
food and nutrients, and used 
a validated diet assessment 
instrument.
For alcohol intake less than 60 g
per day breast cancer risk
increased linearly with increasing 
intake.
Pooled multivariate RR for an
increment of 10 g per day of 
alcohol (about 0.75-1 drink) was
1.09 (1.04-1.13).
Multivariate-adjusted RR for total
alcohol intake of 30 to <60 g per
day (about 2-5 drinks) vs. 
nondrinkers was 1.41 (1.18-1.69).
Limited data suggested that 
alcohol intake of at least 60 g per
day were not associated with 
further increased risk.
The specific type of alcoholic
beverage did not strongly influence 
risk estimates.
The association between alcohol
intake and breast cancer was not 
modified by other factors.
Alcohol consumption
is associated with a 
linear increase in
breast cancer 
incidence in women
over the range of
consumption reported
by most women.
Among women who 
consume alcohol
regularly, reducing 
alcohol consumption is
a potential means to 
reduce breast cancer 
risk.
Longnecker
1993
146 
To evaluate the association
between alcohol
consumption and risk of
breast cancer.
MEDLINE from 1996 through
September 1992, all
abstracts presented at the 
society for Epidemiology
Research from 1989-1994.
RR of breast cancer following daily
alcohol consumption were 
1.11 (1.07-1.16) for one drink, 
1.24 (1.15-1.34) for two drinks, and
1.38 (1.23-1.55) for three drinks.
Causal role of alcohol
remains uncertain.
Evidence base:
38 epidemiology studies
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Table 2. Systematic reviews/meta-analyses for colorectal cancer epidemiology studies
Conclusions
Resources Searched and as Reported by
 
Study
 Objective ResultsInclusion Criteria Study Authors
Mizoue et al. To examine the Population-based cohort studies that In men, multivariate-adjusted pooled hazard When compared to
147
2008 association were conducted in Japan, started ratios for alcohol intake of 23-45.9 g per day, Western populations, 
between alcohol between the mid-1980s and the 46-68.9 g per day, 69-91.9 g per day, and alcohol-colorectal
consumption and mid-1990s, included more than 30,000 >92 g per day, compared with nondrinkers, cancer association
colorectal cancer participants, obtained information on were 1.42 (1.21-1.66), 1.95 (1.53-2.49), seems to be more 
in Japanese. diet, including alcohol intake, using a 2.15 (1.74-2.64), and 2.96 (2.27-3.86), evident in Japanese.
validated questionnaire or a similar one respectively (p for trend <0.001).
at baseline, and collected incidence The association was evident for both the 
data for colorectal cancer during the colon and the rectum. A significant positive 
follow-up period. association was also observed in women.
Evidence base (5 cohort studies): Twenty-five percent of colorectal cancer 
cases were attributable to an alcohol
The Japan Public Health Center-
consumption of >23 g per day.
based Prospective Study (JPHC)
The Japan Collaborative Cohort 
Study (JACC)
The Miyagi Cohort Study
The Takayama Study
o	 According to the authors, 
the JPHC was treated as two 
independent studies (JPHC I 
and JPHC II) because of a 
difference in the dietary
questionnaires used; thus, data 
from a total of five studies were 
analyzed.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Moskal et al.
148
2007
To examine if
current alcohol
intake is
associated with 
risk of colon and
rectal cancer 
by summarizing 
the results of
published 
prospective cohort 
studies with
meta-analytic
techniques.
Prospective cohort studies in MEDLINE High alcohol intake was significantly Lifestyle 
published in English between 1990 and associated with increased risk of colon 1.50 recommendations for 
June 2005; (iii) referenced in MEDLINE. (1.25-1.79) and rectal cancer 1.63 (1.35- prevention of
Since studies on specific types of 1.97). This was comparable to a 15% colorectal cancer 
alcohol (beer, wine, and liquor) were increase of risk of colon or rectal cancer for should consider
limited, the authors restricted the meta- an increase of 100 g of alcohol intake per limiting alcohol intake.
analyses to total alcohol consumption week. The association did not change
on colorectal cancer risk. Studies in significantly by anatomical site (colon, 
particular populations (i.e., cohorts of rectum).
alcoholics or brewery workers) were not 
included.
Evidence base:
Sixteen prospective cohort studies
MEDLINE from 1965 to 2005 A moderate or strong positive association was Among the Japanese 
Inclusion criteria: observed between alcohol drinking and colon population, alcohol
cancer risk in all large-scale cohort studies, consumption perhaps
Epidemiology studies on the with some showing a dose-response may increase the risk
association between alcohol drinking relationship, and among several case-control of colorectal cancer.
and colorectal cancer incidence or studies. Association with 
mortality among Japanese.
Evidence base:
Eighteen studies (5 cohort studies and 
13 case-control studies).
A positive association with rectal cancer was
also reported, but it was less consistent, and
the magnitude of the association was
generally weaker compared with colon
colon cancer is
probable, and that for 
rectal cancer is
possible.
cancer.
The RR of colon or colorectal cancer
increased even among moderate drinkers
consuming <46 g of alcohol per day, levels
at which no material increase in the risk was
observed in a pooled analysis of Western 
studies.
Mizoue et al.
2006
149 
To review
epidemiology
findings regarding 
the association
between alcohol
drinking and
colorectal cancer 
among the
Japanese
population.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Cho et al. 
2004
36 
To examine the
relationship of total
The authors reported a pooled analysis
of primary data from 8 cohort studies in 
Increased risk for colorectal cancer was
limited to persons with an alcohol intake of
alcohol intake and 5 countries. 30 g/day or greater (approximately >2 drinks
intake from per day), a consumption level reported by
specific beverages 4% of women and 13% of men.
to the incidence of
colorectal cancer 
and to evaluate 
whether other 
potential risk
factors modify the 
association.
Compared with nondrinkers, the pooled RR 
were 1.16 (0.99-1.36) for persons who
consumed 30 to <45 g per day and 
1.41 (1.16-1.72) for those who consumed
≥45 g per day (p for trend <0.001).
Evident for cancers of the proximal colon, 
distal colon, and rectum. No clear difference 
in relative risks was found among specific
alcoholic beverage.
There was a 
correlation between a 
single determination
of alcohol
consumption and a
modest relative 
elevation in the rate
of colorectal cancer, 
mostly at the highest 
levels of
consumption.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Corrao et al. 
145
1999
To compare the 
strength of the 
evidence provided
by the
epidemiology
literature on the
association
between alcohol
consumption and 
the risk of six
cancers (oral
cavity, esophagus, 
colorectum, liver, 
larynx, breast).
MEDLINE from 1966 up to and 

including 1998, articles reported by
 
other bibliographic databases available 

at the University of Miami (Current 

Contents from 1996, EMBASE from
 
1980, CAB abstracts from 1973, and 

Core Biomedical Collection from 1993).
 
Evidence base:
 
200 epidemiology studies
 
(16 colon [12 case-control, 4 cohort], 

14 rectum [11 case-control, 3 cohort]).
 
Colon studies**
RR for dose of alcohol intake in colon studies
(case-control) were 1.0 (1.0-1.1) for 25 g per
day, 1.1 (1.0-1.2) for 50 g per day, and 1.1 
(1.0-1.3) for 100 g per day.
RR for dose alcohol intake in colon studies
(cohort studies) were 1.4 (1.1-1.7) for 25 g
per day, 1.9 (1.3-2.9) for 50 g per day, and
3.6 (1.6-8.5) for 100 g per day.
**Reported results were stratified by study
design
Rectum studies***
RR for dose of alcohol intake in rectum
studies among men were 1.1 (1.0-1.2) for 
25 g per day, 1.2 (1.1-1.5) for 50 g per day, 
and 1.5 (1.2-2.2) for 100 g per day.
RR for dose of alcohol in rectum studies
among women were 2.3 (1.3-4.0) for 25 g per
day, 5.0 (1.6-16.4) for 50 g per day, and 25.7 
(2.5-267.6) for 100 g per day.
***Reported results were stratified by gender
Based on weak dose-
response relationship,
there is need for well-
conducted 
epidemiology studies.
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Conclusions
Resources Searched and as Reported by
Study Objective ResultsInclusion Criteria Study Authors
Evidence base:
La Vecchia 
Franceschi and To evaluate
alcohol 34 studies (15 cohort, 19 case-control).150
1994 consumption and 
the risk of cancers
of the stomach 
and colon-rectum.
Among the 15 cohort studies: seven studies Epidemiology
were not very informative; and overall evidence regarding a
evidence from 8 studies showed colon cancer causal role of
RR estimates varying within a narrow range alcoholic beverage
of 1.0-1.7 [ranging between 1.1-1.3 in most consumption and 
studies], and rectal cancer 1.0-2.5 [ranging colorectal
between 1.0-1.7 in most studies]. carcinogenesis
remains inconclusive.Among the 19 case-control studies: five 
studies were totally negative, and showed 
no evidence of association; 3 other studies
showed overall significant associations; and 
remaining 11 studies showed no consistent 
overall association.
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Reported Mechanisms in the Epidemiology Literature
A search of the literature identified the following mechanisms reported in breast and
colorectal cancer epidemiology studies that were not included in our primary evidence base
(see Table 3 and Table 4, respectively). These studies investigated the association between
alcohol consumption and increased cancer risk primarily by administering questionnaires to
study dietary behavior and amount of alcohol consumption and correlated these findings
with cancer incidence. Some of these studies looked at different alcoholic beverages, for
example wine, beer, and other spirits. However, none of these studies controlled alcohol
exposure.
Our searches of the literature identified hypothesis-generating studies that provide indirect 
evidence of potential mechanisms. These studies examined various metabolic pathways that
have been proposed as potential connections between alcohol exposure and increased breast
or colorectal cancer risk (see Table 5 and Table 6, respectively).
These hypothesis-generating studies and epidemiology studies were incorporated into this
report in order to review and discuss this literature base in comparison with our primary evidence
base.
Table 3. Breast cancer epidemiology studies
Proposed Mechanism References
Changes in circulating hormone levels
37,151-158 
DNA-adduct formation
159 
Changes in levels of insulin-like growth factor
160 
Changes in levels of biomarkers of inflammation
77-81 
Cytochrome P450 polymorphism
161,162 
Methylenetetrahydrofolate reductase polymorphism/Dietary/Vitamins 
38,163-173 
Alcohol dehydrogenase/Acetaldehyde dehydrogenase polymorphism
45,47-50,174-178 
Other types of polymorphism
179-184 
Table 4. Colorectal cancer epidemiology studies
Proposed Mechanism References
DNA repair polymorphisms
90,166,185-234 
Hyperproliferation of rectal mucosa
141,235 
Colonic microbial metabolism resulting in the generation of acetaldehyde 
55,56 
Cytochrome P450 polymorphism
236-240 
Alcohol dehydrogenase and acetaldehyde dehydrogenase polymorphism 
19,241-252 
Changes in levels of insulin-like growth factor
253-256 
Impact of C-reactive protein and Inflammation
257,258 
Methylenetetrahydrofolate reductase polymorphism/Dietary/Vitamins 
189,259-263 
Other types of polymorphism and mechanisms
259,264-294 
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Table 5. Hypothesis-generating breast cancer studies
Study Reported Mechanism
Marietta et al. 
2009
295 
Stimulation of Fanconi anemia–breast cancer associated (FANC–BRCA) DNA
damage response network by acetaldehyde
Taibi et al.
2009
296 
Low levels of both xanthine dehydrogenase and cellular retinol binding protein
Jin et al.
2008
297 
Activation of BRCA2 transcription by estrogen receptor-beta
Maciel et al. 
2004
298 
Inhibition of bioactivation of ethanol to acetaldehyde by folic acid
Jordao et al. 
2004
299 
Increased lipid peroxidation
Stevens et al. 
2000
300 
Change in estrogen levels
Colantoni et al. 
2000
301 
Increased levels of malondialdehyde
Jones et al. 
1998
302 
Response of MCF-7 cells to potential estrogens and non-estrogenic substances
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Table 6. Hypothesis-generating colorectal cancer studies
Study Reported Mechanism
Jelski et al. 
2004
15 
Alcohol dehydrogenase and aldehyde dehydrogenase polymorphisms
Vincon et al. 
2003
303 
Generation of free radicals.
Leuratti et al. 
2002
304 
DNA adduct formation
Parlesak et al. 
2000
305 
Inhibition of retinol oxidation
Koivisto et al. 
1996
306 
Alcohol dehydrogenase polymorphism
Jokelainen et al. 
1996
57 
Generation of acetaldehyde by human colonic bacteria
Seitz et al. 
1996
21 
Alcohol dehydrogenase polymorphism
Nosova et al., 
1996
307 
Generation of acetaldehyde by human colonic bacteria
Rosenberg et al.
1994
308 
Induction of cytochrome P450
Jokelainen et al. 
1994
309 
Generation of acetaldehyde by human colonic bacteria
Shimizu et al. 
1990
310 
Induction of cytochrome P450
Ongoing Clinical Trials
A search of the clinicaltrials.gov (http://clinicaltrials.gov/) Web site did not identify any
ongoing trials related alcohol consumption and possible causal mechanisms for breast and 
colorectal cancers. 
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Chapter 4. Discussion
 
Breast Cancer
Key Question 1. What are the likely causal mechanisms by which alcohol contributes to the
development of breast cancer? Which of the possible mechanisms (e.g., induction of P450 
cytochromes and carcinogen metabolism, effects on blood hormone concentrations, effect of
acetaldehyde or other alcohol metabolite on apoptosis and DNA repair, interactive effects on 
other nutritional factors, or others) are likely to be most important in breast cancer 
development?
Alcohol-related Changes in Circulating Hormones
Changes in circulating hormone levels due to chronic alcohol intake have been demonstrated 
in several epidemiology studies (see Table 3). Our searches identified eight epidemiology studies
37,151-157 151-157 that looked at this connection. Seven studies made specific reference that moderate 
alcohol consumption may be responsible for increasing breast cancer risk by influencing
hormonal levels and estrogen receptors and one study37 reported light-to-moderate alcohol 
consumption was not associated with increase breast cancer risk. The findings from these seven 
studies suggest that alcohol interferes with estrogen pathways, thereby causing changes in 
hormonal levels and estrogen receptors. This may then have a direct effect on breast tissue and 
cancer risk. Given this apparent connection between alcohol intake and alterations in circulating
hormones seen in the epidemiology literature, we looked for hypothesis-generating studies that 
examined this connection.
A majority of the human and animal studies identified in our searches and included in our 
primary evidence base also point to a connection between alcohol intake and changes in 
blood hormone levels, especially elevated levels of estrogen-related hormones in humans (see
Table C-1 in Appendix C) and animals (see Table C-2 in Appendix C). Several cell line studies 
also suggest that estrogen receptor pathways may be altered by ethanol (see Table C-3 in 
Appendix C). Increased estrogen levels may increase the risk of breast cancer through increases 
in cell proliferation and alterations in estrogen receptors. Suzuki et al.142 looked at the possible 
connection between estrogen receptor (ER) alterations, alcohol intake, and the risk of breast 
cancer in a meta-analysis of epidemiology studies (see Table 1.). The highest versus the lowest 
alcohol consumption categories were analyzed for their association with all ER+ and ER-
subtype tumors. Meta-analysis of all studies using relative risk (RR) indicated a statistically
significant 27% higher risk of developing ER+ tumors (95% CI: 1.17 to 1.38) and a 14% higher 
risk for developing ER- tumors (95% CI: 1.03 to 1.26) in the high consumption group. The
authors concluded that they had “found support for a positive relationship between alcohol 
consumption and the development of all ER+ tumors.” The authors also concluded that “The
results from these meta-analyses suggest that the biological mechanism for development of 
breast cancer due to alcohol intake could be explained not only through ER-mediated classical 
estrogen-dependent pathway but also through other mechanisms” such as DNA damage or
increased expression of other signaling pathways leading to cell proliferation. These studies 
(human, animal, and cell line) combine to suggest that estrogen-related mechanisms may be
altered by alcohol consumption and provide a potential causal mechanism by which alcohol
affects the estrogen receptors thereby contributing to the increased risk of development of breast 
cancer.
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Elevation in prolactin levels was examined in one human study. Ginsburg et al.87 reported 
that serum prolactin levels increased in menopausal women during acute ethanol ingestion. 
In animal studies, ethanol-induced hyperprolactinemia in mice was associated with the 
97,98 development of mammary tumors. While not as extensive as the estrogen-related studies, 
these studies give some indication that alcohol consumption may alter prolactin levels and 
increase the risk of developing breast cancer.
Cell Proliferation and Tumor Progression
Although we did not identify any epidemiology study that reported on hyperproliferation
as a possible mechanism, enhancement of cell proliferation and tumor progression related to 
ethanol consumption and conversion to acetaldehyde and its connection to breast cancer has been 
examined in numerous animal (Table C-2 in Appendix C) and cell line studies (Table C-3 in 
93,94 Appendix C). Several of the animal studies used carcinogens such as MNU or
100,101,105 DMBA. However, the DMBA studies were not as consistent in showing a relationship 
between ethanol and mammary tumorigenesis as the MNU studies (see Table C-2 in 
Appendix C). The effect of ethanol on cell proliferation in cell lines was examined in three
studies included in this report. Izevbigie et al.51 reported that ethanol stimulated cell proliferation 
in the MCF-7 cell line, Zhu et al.109 reported that ethanol induced changes that could promote
cancer development in the T4TD cell line, and Przylipiak et al.110 reported that ethanol had direct 
growth stimulatory effects on the MCH cell line. Enhancement of cell proliferation and tumor
progression as a potential causal mechanism linking ethanol and breast cancer has some support 
but human subject studies are needed to further explore this connection. According to 
Dumitrescu and Shields, estrogen-induced breast cancer may be as a result of cell proliferation, 
activation of CYP2E1, and DNA damage.10 
Polymorphism in Ethanol Metabolism
Our searches identified a number of epidemiology studies proposing that both genetic and 
enzyme polymorphisms contribute to the promotion of breast cancer development in individuals 
who consume alcohol (see Table 3). Polymorphisms examined in these studies include
161,162 38,163-173 cytochrome P450, methylenetetrahydrofolate reductase, and alcohol 
45,47-50,174-178 dehydrogenase and acetaldehyde dehydrogenase. The majority of these studies
reported enzyme polymorphism as a risk marker for breast cancer following moderate
alcohol consumption. Our searches did not identify any experimental studies in humans or
animals that examined this issue.
DNA Adduct Formation
DNA adduct formation was examined in an epidemiology study by Rundle et al.159 The
authors investigated the association between alcohol consumption and DNA adduct levels in 
breast tissue in women diagnosed with ductal carcinoma in situ and invasive ductal or lobular 
cancer (i.e., cases) vs. women with benign conditions without atypia (i.e., controls). In tumor and 
nontumor tissue from cases, adduct levels were increased among drinkers compared to 
nondrinkers. However, among controls, no increase in adduct levels were found regardless of 
drinking status.159 
We identified no experimental human studies that examined this mechanism. We did identify
experimental studies using animals that suggest intake of ethanol does increase adduct formation 
and could contribute to breast cancer risk.96 Cell line studies also suggested that the formation of 
107,108 DNA adducts increases after incubation with ethanol.
46
 
    
   
   
     
 
     
     
 
 
 
 
 
 
 
 
 
 
  
 
 
  
    
 
  
  
   
    
   
   
Other Potential Mechanisms
A single human study by Hartman et al.76 reported on increased level of biomarkers of
oxidative stress such as α-tocopherol and isoprostane after alcohol consumption (see Table C-1
77-81 in Appendix C). Our searches identified five epidemiology studies that also postulated a
connection between biomarkers of inflammation, alcohol intake, and risk of breast cancer.
77,79 81Increased levels of biomarkers such as malondialdehyde, isoprostanes, and catalase
78,80 activity were reported. We did not identify any experimental studies using animal or cell line
models that examined other potential mechanisms.
Key Question 2. For the most likely mechanisms of action involving alcohol and the 
development of breast cancer, how might other factors modify the effect of alcohol on breast 
cancer (for example, age, latency of effect, intensity, duration, and recency of exposure, presence
of co-carcinogens, presence of threshold effect)? Do the causal mechanisms vary by cell type or 
other tumor characteristics?
For this Key Question, we looked for studies that evaluated factors that modify the 
association of alcohol with biomarkers of risk of breast cancer. The human studies of alcohol 
consumption and hormone changes were performed in pre- and postmenopausal women but an 
actual age effect was not examined in these studies. The duration of consumption was relatively
short; long term effects could not be calculated in these studies. However, we did identify one
human study that examined biomarkers of oxidative stress and risk of carcinogenesis. Hartman et 
al. reported that in postmenopausal women who consumed 30 g alcohol per day, α-tocopherol 
decreased by 4.6% and isoprostane levels increased by 4.9%.76 This study provides a possible 
link between oxidative stress and risk of breast cancer formation.
Table 7 and Table 8 contain an overview of the breast cancer studies included in this report
in terms of study design and reporting issues that determined whether the study provides 
evidence of a direct or an indirect association between alcohol consumption and breast cancer.
Route of administration, rate of absorption and metabolism, formulation and quantity of ethanol, 
and timing of the intervention, however, may reduce the generalizability of animal studies to a 
clinical setting. Although we evaluated cell line studies as part of our overall evidence
evaluation, we did not include them in this table given that events such as confounding exposure, 
control for other risk factors, and cancer formation are not applicable to this model.
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Table 7. Overall results from human breast cancer studies
Study
*Confounding
Exposure
Cancer
Formation
Surrogate 
Outcome 
Measure
Authors Reported
on Causal 
Mechanism
Number of
Links in the 
Pathway of
Carcinogenesis
Hartman et al.
2005
76 
N N Y Y 1
Dorgan et al.
2001
85 
Same as
311 
N N Y Y 1
Ginsburg et al.
1996
88 
N N Y Y 1
Ginsburg et al.
1995
87 
N N Y Y 1
Reichman et al. 
1993
86 
N N Y Y 1
*Confounding exposure: did study administer a carcinogen and /or acetaldehyde?
Y: there was confounding exposure
N: there was no confounding exposure
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Table 8. Overall results from animal breast cancer studies
Study
*Confounding
Exposure
Cancer
Formation
Surrogate 
Outcome 
Measure
Authors Reported
on Causal 
Mechanism
Number of
Links in the 
Pathway of
Carcinogenesis
Hilakivi-Clarke et al. 
2004
92 
Y Y N Y 1
Castro et al.
2003
95 
N N Y Y 1
Chhabra et al.
2000
96 
Y N Y Y 1
Watabiki et al.
2000
97 
N N Y Y 1
Holmberg et al. 
1995
91 
N Y N N 0
Singletary et al.
1995
93 
Y N Y N 0
Singletary and 
McNary 1994
94 
Y N Y Y 1
Taylor et al.
1993
99 
Y N Y Y 1
McDermott et al. 
1992
101 
Y Y N N 0
Hackney et al.
1992
102 
N Y N N 0
Singletary and 
McNary 1994
104 
N N Y Y 1
Singletary et al.
1991
105 
Y N Y Y 1
Rogers and Conner 
1990
100 
Y Y N N 0
Grubbs et al.
1988
103 
Y Y N N 1
Schrauzer et al. 
1979
98 
Y N Y Y 1
*Confounding exposure: did study administer a carcinogen and /or acetaldehyde?
Y: there was confounding exposure
N: there was no confounding exposure
Colorectal Cancer
Key Question 3. What are the likely causal mechanisms by which alcohol contributes to the
development of colorectal cancer? Which of the possible mechanisms (e.g., induction of P450
cytochromes and carcinogen metabolism, effects on blood hormone concentrations, effect of
acetaldehyde or other alcohol metabolite on apoptosis and DNA repair, interactive effects on 
other nutritional factors, or others) are likely to be most important in colorectal cancer 
development?
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Acetaldehyde production in the colon. Exposure of colon mucosa to acetaldehyde from 
microbial metabolism of ethanol has been postulated as a mechanism for increasing the risk of
55,56 developing colorectal cancer in two epidemiology studies (see Table 4) and three
57,307,309 experimental studies (see Table 5). According to study authors, individual variations in
human colonic flora may contribute to the risk of alcohol-related colorectal cancer,55 and
increased activity of intracolonic bacterial alcohol dehydrogenase may also play a role in
56,57,307,309 increasing cancer risk.
Experimental human studies examining this subject are few (see Table C-4 in Appendix C). 
A study by Basuroy et al.83 suggests that acetaldehyde disrupts epithelial tight junction and cell
adhesion and through this mechanism increases the risk of colon cancer. Several animal studies 
also looked at the effects of acetaldehyde in the colon (see Table C-5 in Appendix C). These
120 70studies showed mucosal damage after ethanol consumption, increased degradation of folate,
stimulation of rectal carcinogenesis,122 and an increased effect of carcinogens in the presence of 
acetaldehyde.123 In cell line studies acetaldehyde exposure was reported to influence the initial 
steps of colonic carcinogenesis and later tumor development136 and decrease the activity of some
brush border enzymes.137 Finally, a study using animal and cell line tissue found evidence that 
acetaldehyde stimulates cell proliferation in animal intestinal crypt cells and therefore
acetaldehyde may act as a cocarcinogen in the colon.141 These studies suggest that acetaldehyde
production in the colon may provide a potential causal mechanism by which alcohol contributes 
to the development of colon cancer.
Cell proliferation. Hyperproliferation of rectal mucosa after exposure to alcohol was 
postulated as a mechanism for increasing the risk of developing colorectal cancer in an 
epidemiology study by Simanowski et al.235 The authors examined rectal biopsies for
proliferation markers such as histone H3 and Ki67 in 44 heavy drinkers and 26 controls. Heavy
drinkers showed an increase in cell proliferation markers in the rectal mucosa compared to 
controls.235 
An effect of ethanol consumption on cell proliferation in the colon was investigated in both 
animal and cell line studies in our primary evidence base. Several animal studies reported 
125-127 enhanced growth of mucosal tissue after chronic ethanol consumption. Cell studies 
74,136 indicated that exposure to ethanol and acetaldehyde increases cell proliferation and damages 
DNA which may contribute to cancer development.135 Together these studies suggest that 
ethanol and acetaldehyde exposure in the colorectal mucosa may increase cell proliferation and 
be a potential mechanism connecting alcohol consumption to colorectal cancer risk.
DNA repair polymorphism. We identified 52 epidemiology studies that assessed DNA
repair polymorphism and alcohol consumption. The majority of these studies suggested that 
DNA repair polymorphism may influence the risk of colorectal cancer.
Enzyme polymorphism. We identified 19 studies that assessed enzyme polymorphism in 
epidemiology studies: 13 examined alcohol and acetaldehyde dehydrogenase
19,241-252 236-240 polymorphism; five examined cytochrome P450 polymorphism; and six
189,259-263 examined methylenetetrahydrofolate reductase polymorphism. The majority of
these studies reported enzyme polymorphism as a risk marker for colorectal cancer
following moderate alcohol consumption.
Other potential mechanisms. Ethanol may also influence carcinogenesis in the colon and 
rectum through an interaction with carcinogens. Animal studies suggest that ethanol exposure in 
the colon increases the chances of tumor development,132 but other studies found no association 
between ethanol ingestion and colorectal carcinogenesis or instead reported inhibition of 
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73,130,131 tumorigenesis. Other possible mechanisms reported in animal studies include alcohol’s 
70 124inhibition of folate metabolism and DNA hypomethylation.
Key Question 4. For the most likely mechanisms of action involving alcohol and the 
development of colorectal cancer, how might other factors modify the effect of alcohol on 
colorectal cancer (for example, age, latency of effect, intensity, duration, and recency of 
exposure, presence of co-carcinogens, presence of threshold effect)? Do the causal mechanisms 
vary by cell type or other tumor characteristics?
For this Key Question, we looked for studies that evaluated factors that modify the 
association of alcohol with biomarkers of colorectal cancer risk. Few studies are available that 
examined factors that modify the effects of ethanol consumption on the risk of developing
colorectal cancer. The study in human subjects in which biopsy samples were examined for
damage after exposure to acetaldehyde did not report the influence of personal factors on the 
degree of damage generated.83 
Table 9 and Table 10 contain an overview of the colorectal cancer studies included in this
report in terms of study design and reporting issues that determined whether the study provides 
evidence of a direct or an indirect association between alcohol consumption and colorectal 
cancer. Route of administration, rate of absorption and metabolism, formulation and quantity of 
ethanol, and timing of the intervention however may reduce the generalizability of animal studies 
to a clinical setting. Although we evaluated cell line studies as part of our overall evidence
evaluation, we did not include them in this table given that events such as confounding exposure, 
control for other risk factors, and cancer formation are not applicable to this model.
Table 9. Overall results from human colorectal cancer study
Study
*Confounding
Exposure
Cancer
Formation
Surrogate 
Outcome 
Measure
Authors
Reported on 
Causal 
Mechanism
Number of
Links in the 
Pathway of
Carcinogenesis
Basuroy et al.
2005
83 
Y N Y Y 1
*Confounding exposure: did study administer a carcinogen and/or acetaldehyde?
Y: there was confounding exposure
N: there was no confounding exposure
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Table 10. Overall results from animal colorectal cancer studies
Study
*Confounding
Exposure
Cancer
Formation
Surrogate 
Outcome 
Measure
Authors
Reported on
Causal 
Mechanism
Number of
Links in the 
Pathway of
Carcinogenesis
Hayashi et al.
2007
118 
Y N Y Y 1
Perez-Holanda et al. 
2005
73 
Y N N N 0
Pronko et al.
2002
120 
N N Y Y 1
Roy et al.
2002
121 
N N Y N 1
Homann et al.
2000
70 
N N Y N 1
Choi et al.
1999
124 
N N Y Y 1
Hakkak et al.
1996
119 
N N Y Y 1
Simanowski et al.
1994
125 
N N Y Y 1
Niwa et al.
1991
126 
Y N Y Y 1
Seitz et al.
1990
122 
Y N Y Y 1
McGarrity et al.
1988
129 
Y N Y Y 1
Hamilton et al.
1988
130 
Y N Y Y 1
Garzon et al.
1987
128 
Y Y N Y 1
Hamilton et al.
1987
132 
Y N Y Y 1
Hamilton et al.
1987
131 
Y N Y Y 1
Simanowski et al.
1986
127 
N N Y Y 1
Nelson et al.
1985
116 
Y N N N 0
Seitz et al.
1985
123 
Y N Y Y 1
Howarth et al.
1984
117 
Y N N N 0
*Confounding exposure: did study administer a carcinogen and/or acetaldehyde?
Y: there was confounding exposure
N: there was no confounding exposure
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Excluded Studies
Because this is a systematic review using specific inclusion and exclusion criteria with the 
creation of specific Key Questions, the report is directed at evidence that addresses each 
Key Question. None of the excluded studies (see Table D-1 in Appendix D) were left out for
quality, design, conduct, integrity, or inaccuracy but rather because they did not address these
Key Questions.
Future Research Goals
Our examination of the epidemiology literature correlating alcohol consumption with cancer 
risk has suggested many areas in which experimental research may provide insight into the actual 
mechanisms connecting cancer risk and alcohol consumption. For breast cancer these potential 
mechanisms are changes in circulating hormone levels and changes in hormone receptors, 
DNA-adduct formation, and various enzyme polymorphisms related to alcohol metabolism. 
For colorectal cancer these areas are DNA repair polymorphisms, mucosal cell proliferation, and 
various enzyme polymorphisms related to alcohol metabolism. Experimental studies in humans, 
animals, or cell lines have provided basic information on some but not all of these potential 
mechanisms.
The connection between alcohol intake and changes in estrogen levels and breast cancer risk 
has been studied in human, animal, and cell line studies. Future research in this area would seem 
to be warranted to determine the exact level of risk imposed by this pathway. A connection 
between cell proliferation and tumor progression in breast cancer has been suggested by animal 
studies but not in human studies and human-based studies in this area would seem to be
warranted. Enzyme polymorphism in ethanol metabolism as well as in other metabolic pathways 
that may be influenced by alcohol may require more human-based studies as opposed to animal 
studies where polymorphism is not a factor. DNA adduct formation has not been well studied in 
human or animal studies and research in this area should be expanded. Oxidative stress and 
inflammation associated with alcohol consumption have been postulated as risk factors in 
epidemiology studies but not studied to any extent in hypothesis-generating studies. Oxidative 
stress and inflammation should be examined with better experimentally controlled studies.
Experimental human studies examining the connection between alcohol intake and colorectal 
cancer are few. Many potential mechanisms related to acetaldehyde production in the colon, 
cell proliferation due to ethanol or acetaldehyde exposure, alterations in DNA repair
mechanisms, and the influence of carcinogens and alcohol in the colon need to be examined in 
human-based studies. Animal studies are also needed to examine the influence of bacterial flora, 
the effects of ethanol and acetaldehyde on the colon, especially changes in cell proliferation and 
DNA, and the interaction between carcinogens and ethanol and acetaldehyde.
Conclusions
Based on our systematic review of the literature, many potential mechanisms by which 
alcohol may influence the development of breast or colorectal cancers have been explored but 
the exact connection or connections remain unclear. The evidence points in several directions but
the importance of any one mechanism is not apparent at this time.
Table 11 through Table 13 summarizes the mechanisms on alcohol consumption and the risk 
of breast cancer as presented in studies identified in this report. Six human, five animal and 
five cell line studies reported on changes in hormonal levels as the potential causal mechanism
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by which alcohol consumption may contribute to the development of breast cancer. Our findings 
are comparable to the most commonly reported mechanisms in most of the breast cancer 
epidemiology studies summarized in Table 3.
Table 11. Reported mechanisms in human breast cancer studies
Number
of 
Mechanism Reported by Study Authors ReferencesStudies
Change in levels of estrogen, progesterone, and DHEA 2
85,311 
Change in level of estrogen 1
88 
Elevation of prolactin 1
87 
Elevation of estrogens and DHEA 1
86 
Table 12. Reported mechanisms in animal breast cancer studies
Number
of 
Mechanism Reported by Study Authors ReferencesStudies
Change in level of estrogen 3
92-94 
Biotransformation of ethanol to acetaldehyde 1
95 
Formation of DNA adducts 1
96 
Elevation of prolactin 2
97,98 
Effects on DNA synthesis 2
104,105 
Suppression of cellular immunity 1
99 
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Table 13. Reported mechanisms in cell line breast cancer studies
Number
of 
Mechanism Reported by Study Authors ReferencesStudies
Effect on estrogen receptor- α expression 5
65,67-69,106 
Effect on peroxisome proliferator-activated receptor (PPAR)-α and PPAR-β 
transactivation
1
115 
Formation of DNA adducts 2
107,108 
Disruption and modulation of cell proliferation 2
51,109 
Upregulation of transcription of smooth muscle myosin alkali light chain 1
114 
Upregulation of mammary gland mucin 1
113 
Direct growth stimulatory effect by enhancement on 3H-thymidine 1
110 
Change in potassium channels 1
112 
Increase cAMP levels 1
111 
Table 14 through Table 17 summarizes the mechanisms of alcohol consumption and the risk 
of colorectal cancer as presented in studies identified in this report. One human study exposed
colonic mucosa biopsies to vapor-phase acetaldehyde and reported an effect of acetaldehyde on 
cell adhesion as the most likely causal mechanisms by which alcohol consumption may
contribute to the development of colorectal cancer. In contrast, nine animal studies reported a 
local toxic effect of acetaldehyde resulting in mucosal damage as the most likely causal 
mechanism by which alcohol consumption may contribute to development of colorectal cancer. 
Other mechanisms identified in this report include:
increase in cytochrome P4502E1 expression (two animal studies)
effect on DNA synthesis and methylation (two animal studies, two cell line studies)
effect on cell proliferation (two cell line studies)
apoptotic cell death (three cell line studies)
effect on various stages of carcinogenesis (two animal studies)
changes in polyamine content (one animal study)
effect of acetaldehyde on brush border enzymes (one cell line study)
modulation of gene expression (one cell line study).
Our findings are comparable to some of the most common mechanisms (e.g., colonic
microbial production of acetaldehyde, effect on DNA methylation and synthesis) reported by the 
colorectal cancer epidemiology studies summarized in Table 4.
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Table 14. Reported mechanisms in human colorectal cancer study
Mechanism Reported by Study Authors
Number of
Studies References
Effect of acetaldehyde on cell to cell adhesion 1
83 
Table 15. Reported mechanisms in animal colorectal cancer studies
Mechanism Reported by Study Authors
Number of
Studies References
Local toxic effect of acetaldehyde resulting in mucosal damage and cell
proliferation
9
70,120-123,125-
128 
Increase cytochrome P4502EI expression 2
118,119 
DNA methylation and synthesis 2
132,139 
Effect on various stages of carcinogenesis 2
130,131 
Changes in polyamine content 1
129 
Table 16. Reported mechanisms in cell line colorectal cancer studies
Mechanism Reported by Study Authors
Number of
Studies References
Effect on DNA methylation and synthesis 2
134,140 
Apoptotic cell death 3
75,133,134 
Effect on cell proliferation 3
74,136,138 
Effect of acetaldehyde on brush border enzyme 1
137 
Modulation of gene expression 1
139 
Table 17. Reported mechanisms in combination (animal, cell lines) colorectal cancer study
Mechanism Reported by Study Authors
Number of
Studies References
Effect on cell proliferation 1
141 
Limitations
The evidence base for the report included 66 studies: 
six human studies (five breast cancer, one colorectal cancer)
34 animal studies (15 breast cancer, 19 colorectal cancer)
25 cell line studies (15 breast cancer, 10 colorectal cancer)
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one combination study (animal, cell line) on colorectal cancer. 
Therefore the evidence in support of any potential mechanism connecting alcohol intake to 
cancer development is based largely on animal models. Animal models are important tools for
understanding disease mechanisms but they have limitations when predicting the actual course of
events in humans.82 Reviews of animal studies have shown that there is a tendency to publish 
studies with positive results and not to publish studies that suggest no difference in measured 
outcomes (i.e., publication bias). Therefore studies that could possibly rule out mechanisms 
connecting alcohol and cancer may not be published. Positive results in animal studies may not 
translate to a clinical setting because carcinogens were administered in a controlled setting that is
not characteristic of human conditions. Most experimental animals are young and rarely have
comorbidities, a situation that may also limit generalizability of animal studies to clinical 
studies.312 
Few human studies met the inclusion criteria for this report and this limited the comparisons
that could be made between the findings of animal studies and those in human studies. Exact 
alcohol exposure can be controlled in animal studies but few human studies have done the same. 
While the four breast cancer human studies actually administered and quantified the amount of 
ethanol, the only colorectal cancer study administered acetaldehyde to biopsied colonic mucosa. 
Because of the limited number of human studies in our evidence base, we did look at potential 
mechanisms suggested in epidemiology studies and compared them to mechanisms examined in 
animal and cell line studies.
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List of Acronyms/Abbreviations
 
ADH: alcohol dehydrogenase
ALDH: aldehyde dehydrogenase
AJ: adherens junctions
AMMN: acetoxymethyl-methylnitrosamine
AOM: azoxymethane
BPDE: benzo[a]pyrene diolepoxide
BRCA1: breast cancer type 1
cAMP: cyclic adenosine monophosphate
CM: colonic mucosa
CY: cyanamide
CYP2E1: cytochromes P450 2E1
DHEA: dehydroepiandrosterone
DHEAS: DHEA sulfate
DMBA: dimethylene (a) anthracene
DMH: 1,1-dimethylhydrazine
DNA: deoxyribonucleic acid
EGFR: epidermal growth factor receptor
ER: estrogen receptor
ERT: estrogen replacement therapy
FCS: fetal calf serum
HLA: human leukocyte antigen
H2O2: hydrogen peroxide
H2O: water
JACC: Japan Collaborative Cohort Study
JPHC: Japan Public Health Center-based Prospective Study
MAA: mutagenic malondialdehyde-acetaldehyde
MAM: methylazoxymethanol
MEOS: microsomal ethanol-oxidizing system
MLC: myosin alkali light chain 
MNU: N-methyl-N-nitrosurea
NAD: nicotinamide adenine dinucleotide
NADH: reduced nicotinamide adenine dinucleotide
NMDA: N-nitrosodimethylamine
NNK: 4-methylnitrosoamino-1-3-pyridyl-1-butanone
PK: protein kinase
PPAR: peroxisome proliferator-activated receptor
PR: progesterone receptor
ROS: reactive oxygen species
rp: ribosomal protein
SAM: s-adenosylmethionine
TNF: tumor necrosis factor
TJ: tight junctions
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Appendix A: Exact Search Strings
Electronic Database Searches
The following databases have been searched for relevant information:
Name Date Limits Platform/Provider
Cancerlit 1935 - September 18, 2009 www.pubmed.gov
ClinicalTrials.gov Searched February 1, 2009 www.clinicaltrials.gov
The Cochrane Central Register 
of Controlled Trials (CENTRAL)
Through 2010, Issue 1 www.thecochranelibrary.com
The Cochrane Database of
Methodology Reviews
(Methodology Reviews)
Through 2010, Issue 1 www.thecochranelibrary.com
The Cochrane Database of
Systematic Reviews
(Cochrane Reviews)
Through 2010, Issue 1 www.thecochranelibrary.com
Database of Abstracts of
Reviews of Effects (DARE)
Through 2010, Issue 1 www.thecochranelibrary.com
EMBASE (Excerpta Medica) 1980 through May 3, 2010 OVID
Health Technology Assessment 
Database (HTA)
Through 2010, Issue 1 www.thecochranelibrary.com
MEDLINE 1965 through May 3, 2010 OVID
U.K. National Health Service 
Economic Evaluation Database 
(NHS EED)
Through 2010, Issue 1 www.thecochranelibrary.com
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Medical Subject Headings (MeSH), EMTREE, PsycINFO and Keywords
Conventions:
OVID
$ = truncation character (wildcard)

exp = “explodes” controlled vocabulary term (e.g., expands search to all more specific 

related terms in the vocabulary’s hierarchy)
/ = limit controlled vocabulary heading
.fs. = floating subheading
.hw. = limit to heading word
.md. = type of methodology (PsycINFO)
.mp. = combined search fields (default if no fields are specified)
.pt. = publication type
.ti. = limit to title
.tw. = limit to title and abstract fields
PubMed
[mh] = MeSH heading
[majr] = MeSH heading designated as major topic
[pt] = publication type
[sb] = subset of PubMed database (PreMEDLINE, Systematic, OldMEDLINE)
[sh] = MeSH subheading (qualifiers used in conjunction with MeSH headings)
[tiab] = keyword in title or abstract
A-2
 
    
   
  
 
 
 
 
 
  
  
   
  
  
 
  
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
   
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
  
 
 
  
  
 
  
 
 
Topic-specific search terms – alphabetical listing
Concept Controlled Vocabulary Keywords
Adrenal Adrenal.hw.
exp Adrenal gland/
exp Adrenal glands/
exp Endocrine system/
Adrenal
Aldosterone
Endocrine gland$
Primary hyperaldosteroneism
Alcohol Alcohol
Alcohol abstinence
Alcohol drinking
exp Alcohol-related disorders
exp Alcoholic beverage
exp Alcoholic beverages
Alcohol metabolism
Drinking behavior
Ethanol
Feeding behavior
Food habits
Temperance
Abstinence 
Alcohol$
Beer
Brandy
Cocktail$
EtOH
Gin
Liqueur$
Liquor$
Mixed drink$
Schnapps
Spirits
Vodka
Biochemical Processes Exp biochemical processes/
Breast cancer exp breast cancer
Breast carcinoma
exp Breast diseases
exp Breast neoplasms
Breast$
Cancer$
Carcinoma$
Lesion$
Lump$
Mammar$ 
Tumo?r$
Colorectal cancer Adenomatous polyp
Colorectal cancer
Colorectal carcinoma
Exp colorectal neoplasms
Cancer$
Carcinoma$
Colon$
Colorectal
Lesion$
Polyp$
Rectal
Rectum
Tumo?r$
Experimental neoplasms Experimental neoplasm/
exp Neoplasms, experimental/
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Concept Controlled Vocabulary Keywords
Hypothalamic-hypophyseal
system
Hypothalamo-hypophyseal system
Hypothalamus hypophysis system
Pituitary gland
Hypothalamus hypophysis
gonad system
Microbes Achlorhydria/
Bacteria, aerobic
Candida albicans
Colon flora
Intestine flora
Microbial growth
Microbiology.fs.
microorganism
Bacteria
Bacteriocolonic
Flora 
Microb$
Microflora 
Yeast$
Oncogenesis Breast carcinogenesis
Chemical carcinogenesis
Colorectal carcinogenesis
Malignant neoplastic disease
exp neoplastic processes
exp Oncogenesis and malignant 
transformation
Carcinogenesis
Oncogenesis
Tumorigenesis
Tumorigenic effect 
Potential mechanisms 5,10 methlyenetetrahydrofolate
reductase (FADH2)
Acetaldehyde 
Alcohol dehydrogenase
Aldehyde dehydrogenase
ALDH2
Apoptosis
Calcium signaling
Cell cycle
Cell cycle regulation
Cell division
Cell membrane permeability
Cell nucleus
Cell proliferation
Cyclin dependent kinase 2
cyp2E1
Cytochrome p-450 enzyme system
cytochrome p450 17
cytochrome p450 1A1
cytochrome p450 1A2
Acetaldehyde$
MAPK
MAPKs
NFkappaB
Proto-oncogene
Reactive oxygen
A-4
 
    
  
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Concept Controlled Vocabulary Keywords
cytochrome P450 1B1
cytochrome P-450 CYP1A1
cytochrome P-450 CYP1A2
cytochrome P-450 CYP2B1
cytochrome P-450 CYP2D6
cytochrome P-450 CYP2E1
cytochrome P-450 CYP3A
Deamination
DNA adducts
exp DNA-binding proteins
DNA damage
Down regulation
Estrogen activity
Estrogen metabolism
Estrogen receptor, alpha
Estrogen receptor beta
Fas antigen
Folate metabolism
exp Folic acid
Folic acid
Folic acid deficiency
Gene control
exp Gene expression regulation
Gene function
Gene mutation
Genetic code
Genetic polymorphism
Genetic variability
Growth regulation modulation
hydroxylation
MAP kinase signaling system
Metabolism.fs.
Methionine synthase
Mitochondria
exp Mitogen-activated kinases
Mitogen activated protein kinase
NF-kappa B
Oxidative phosphorylation
Oxidative stress
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Concept Controlled Vocabulary Keywords
p16 protein human.sn.
Polymorphism, genetic
Protein expression
Protein p16
Proto oncogene
Exp reactive nitrogen species
Reactive oxygen metabolite
Exp Reactive oxygen species
Receptor cross talk
Receptor upregulation
exp Receptors, estrogen
exp Receptors, retinoic acid
Retinoid
Retinoic acid receptor beta
exp Signal transduction
exp Transferases
Tretinoin
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EMBASE/MEDLINE
English language, remove overlap
Set 
Number Concept Search Statement
1 Alcohol Alcohol drinking/ or exp alcohol-related disorders/ or alcohol metabolism/
2 exp alcoholic beverage/ or exp alcoholic beverages/ or alcohol/ or ethanol/
or beer or wine or alcohol$ or brandy$ or gin or vodka or schnapps or 
EtOH or liquor$ or liqueur$ or spirits or mixed drink$ or cocktail$
3 Drinking behavior/ or food habits/ or feeding behavior/ or temperance/ or 
alcohol abstinence/ or abstinence
4 Combine sets or/1-3
Oncogenesis
5 Carcinogenesis Exp neoplastic processes/ or exp oncogenesis and malignant 
transformation/ or malignant neoplastic disease/ or breast carcinogenesis/ 
or colorectal carcinogenesis/ or chemical carcinogenesis/ or exp 
neoplasms, experimental/ or experimental neoplasms
6 Carcinogenesis or oncogenesis or tumorigenesis or tumorigenic effect 
7 Combine sets or/5-6
Potential
mechanisms
8 Proto oncogene/ or proto-oncogene or exp DNA-binding proteins/
9 Metabolism.fs. or deamination/
10 Signaling Receptor cross-talk/ or exp signal transduction/ or calcium signaling/ or 
exp gene expression regulation/ or down regulation/ or protein expression/ 
or receptor upregulation/ or growth regulation modulation/
11 Estrogen Estrogen receptor, alpha/ or exp receptors, estrogen/ or estrogen activity/ 
or estrogen metabolism/ or estrogen receptor beta/
12 MAPK Exp mitogen-activated kinases/ or MAP kinase signaling system/ or
mitogen activated protein kinase/ or MAPK or MAPKs
13 Cytochrome 
P-450
Cytochrome p-450 enzyme system/ or cyp2E1/ or cytochrome P450 17/ or 
cytochrome P450 1A1/ or cytochrome P450 1A2/ or cytochrome P450
1B1/ or cytochrome P-450 CYP1A1/ or cytochrome P-450 CYP1A2/ or 
cytochrome P-450 CYP2B1/ or cytochrome P-450 CYP2D6/ or cytochrome 
P-450 CYP2E1/ or cytochrome P-450 CYP3A/
14 Dehydrogenases Alcohol dehydrogenase/ or aldehyde dehydrogenase/ or ALDH2/ or 
acetaldehyde$
15 Methylation exp Folic acid/ or Folic acid/ or folic acid deficiency/ or folate metabolism/
16 DNA methylation/ or RNA methylation/ or DNA hypermethylation/ or DNA
hypomethylation/ or methylation
17 Methionine synthase/
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Set 
Number Concept Search Statement
18 Cyclin dependent kinase 2/ or Fas antigen/ or 5,10 
methlyenetetrahydrofolate reductase FADH2/ or Protein p16/ or p16
protein human.nm.
19 Cells Apoptosis/ or cell division/ or cell proliferation/ or cell cycle/ or cell cycle 
arrest/ or cell cycle regulation/ or cell membrane permeability/ or cell
nucleus/
20 Misc. genetic
concepts
Gene control/ or gene function/ or gene mutation/ or genetic code/ or 
genetic polymorphism/ or genetic variability/ or polymorphism, genetic/
21 DNA DNA adducts/ or DNA damage/ or mitochondria/ or exp DNA-binding
proteins/ 
22 Oxidation Reactive oxygen metabolite/ or oxidative stress/ or hydroxylation/ or exp 
reactive oxygen species/ or oxidative phosphorylation/ or reactive oxygen
or exp reactive nitrogen species/
23 Retinoic acid Retinoid/ or retinoic acid receptor beta/ or exp receptors, retinoic acid/ or 
tretinoin/
24 NF-kappa B/ or NFkappaB
25 Exp transferases/
26 Acetaldehyde Exp acetaldehyde/ or acetaldehyde$
27 Biochemical
processes
(includes DNA
repair)
Exp biochemical processes/
28 Adrenal Exp Adrenal gland/ or exp adrenal glands/ or adrenal.hw. or adrenal.tw. or 
aldosterone or primary hyperaldosteroneism or exp endocrine system/ or
endocrine gland$
29 Hypothalamic Hypothalamo-hypophyseal system/ or hypothalamus hypophysis system/ 
or Hypothalamus hypophysis gonad system or pituitary gland/
30 Microbial Microflora or microbiology.fs. or microb$.ti. or achlorhydria/ or bacteria, 
aerobic/ or candida albicans/ or colon flora/ or intestine flora/ or microbial
growth/ or microorganism/ or bacteria or bacteriocolonic or flora or 
Microflora or yeast$
31 Combine sets
(mechanisms)
or/8-30
32 Breast cancer exp Breast neoplasms/ or exp breast diseases/ or exp breast cancer/ or 
breast carcinoma/ 
33 (breast or mammar$) and (tumo?r$ or lesion$ or cancer$ or carcinoma$ or 
lump$)
34 Combine sets
(breast cancer)
or/32 -33
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Set 
Number Concept Search Statement
35 Colorectal 
cancer
Exp colorectal neoplasms/ or adenomatous polyp/ or colorectal cancer/ or 
colorectal carcinoma/ 
36 (colon$ or rectal or rectum or colorectal) and (tumo?r$ or lesion$ or
cancer$ or carcinoma$ or polyp$)
37 Combine sets
(colorectal
cancer)
or/35-36
38 Combine sets
Alcohol,
oncogenesis & 
breast cancer
4 and 7 and 34
39 Combine sets
Alcohol,
mechanisms &
breast cancer
4 and 31 and 34
40 Combine sets
Alcohol,
oncogenesis &
colorectal cancer
4 and 7 and 37
41 Combine sets
Alcohol,
mechanisms & 
colorectal cancer
4 and 31 and 37
42 Combine sets 38 or 39 or 40 or 41
43 Limit to English 42 and English
44 Non-English 42 not 43
45 Eliminate 
overlap
Remove duplicates from 43
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Appendix B: Sample Data Abstraction Forms
Level 1 – Abstract Review: At this review level abstracts were examined to determine if a
document should be retrieved for further review. Checking the inclusion boxes in the form 
automatically led to retrieval of the full article. All documents selected for inclusion at this level 
fell to the next level for evaluation.
Keywords:
Abstract:
1. Include or Exclude document 
Include
Exclude
Include: Non-English Language
Clear Selection
Level 2 – Full Document Review: At this level we made the final determination as to whether
the document was to be excluded or included in the report. The reason for exclusion was noted in 
a separate box on the form. All documents selected for inclusion at this level fell to the next level 
for evaluation.
Keywords:
1. Is this document included in the Report (includes
Abstract:
Background and Evidence)? 
Include in Report
Exclude
Clear Selection
2. Reason for Exclusion
Enlarge Shrink
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Level 3 – Background Document Review: At this level we determined if the document will appear 
in the Background section of the report or in the Evidence section of the report. If the document 
was to be used as background material this form was used to indicate which area in the
Background section the document belonged. All documents selected for inclusion in the evidence
report at this level fell to the next level for evaluation.
Submit Data
1. Is this document included in the Background only or the Evidence Report? 
Include in Evidence Report
Include in Background Only
Clear Selection
2. If Included for Background only, which of the following apply? 
Basic cancer mechanisms
Breast cancer mechanisms
Colorectal cancer mechanisms
Alcohol metabolism
Epidemiology of alcohol and cancer
Other components of alcoholic drinks
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Level 4 – Evidence Base Document Review: Only documents that were used in the evidence
report appeared at this level. Information recorded at this level was used to organize the 
documents into specific areas of study depending on study design.
Submit Data
1. Which of the following apply to this document? 
Human studies - breast
Animal models - breast
Animal tissues - breast
Cell lines - breast
Human studies - colorectal
Animal models - colorectal
Animal tissues - colorectal
Cell lines - colorectal
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Table B-1. Data abstraction and data management
Document ID#: internal ECRI Institute ID number
Article Citation
Country where study was completed
Year in which the study was performed
Experimental Model: type of animal model or cell line
Primary Mechanism examined: mechanism being tested for relationship between alcohol intake and 
cancer risk
Secondary Mechanism examined: for studies that explore multiple mechanisms
Amount of Alcohol Exposure: levels of alcohol exposure depending on the design of the experiment 
and the experimental model
Mode of Administration: mode of administration of alcohol depending on the design of the experiment 
and the experimental model
Duration of Alcohol Exposure: duration of alcohol exposure depending on the design of the 
experiment and the experimental model
Use of a Carcinogen: the carcinogenic agent, if any, being examined in the study along with alcohol
Use of other non-carcinogen agents: nutritional or other interventional agents utilized to show the
relationship between alcohol intake and cancer risk
Description of subject characteristics in human studies: age, male/female ratio, smoking, 
comorbidities, race/ethnicity, alcoholism
Study design: explains the type of study design
Duration of the study
Direct or Indirect Association: explains evidence of carcinogenesis
Results for Intermediate Outcomes: usually molecular, biochemical, or histological outcomes which 
may be indicative of a direct or indirect relationship between alcohol intake and cancer risk
Results for Clinical Outcomes: typically broader organ measurements that correlate to a direct or
indirect relationship between alcohol intake and cancer risk
Results for Patient Oriented Outcomes: entries in this column are only for human studies
Conclusions: did the study present evidence for or against the proposed mechanism
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Appendix C: Evidence Tables
Evidence Base for Breast Cancer
Table C-1. Summary of results from human studies on breast cancer
Study Model Study Design Mechanism Examined
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as
Reported by
Study Authors
Hartman et al.
2005
76 
53 postmenopausal
women
Case control Increase levels of
biomarkers of
oxidative stress
Controlled diet
plus each of
three treatments
(15 or 30 g
alcohol per day
or no-alcohol
placebo
beverage), during
three 8-week
periods in
random order
After adjusting for 
body mass index
(all models) and
total serum
cholesterol
(tocopherol and
isoprostane
models), there was
a 4.6% decrease
(p = 0.02) in 
α-tocopherol and a 
4.9% increase 
(p = 0.07) in 
isoprostane levels
when women
consumed 30 g 
alcohol/day
(p = 0.06 and 0.05 
for overall effect of
alcohol on a-
tocopherol and
isoprostanes, 
respectively).
Moderate
alcohol
consumption
increases some 
biomarkers of
oxidative stress
in 
postmenopausal
women.
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Study Model Study Design Mechanism Examined
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as
Reported by
Study Authors
Dorgan et al. 
2001
85 
Same as
311 
51 healthy
postmenopausal
women not using
hormone 
replacement 
therapy
Three-period
crossover 
design
Elevated serum levels of
estradiol, estrone,
estrone sulfate, 
testosterone, 
androstenedione, 
progesterone, 
dehydroepiandrosterone 
(DHEA), DHEA sulfate
(DHEAS), and
androstenediol
15 g or 30 g of
alcohol per day
or an alcohol-free
placebo
beverage through 
a three 8-week
dietary period. 
Alcohol was
supplied as
95% ethanol in
12 oz orange 
juice. Each 
dietary period
was preceded by
a 2- to 5-week
washout period
when participants
did not consume 
any alcohol.
15 g of alcohol/day
resulted in an
increase of 7.5% 
(95% confidence 
interval [CI]:
-0.3 to 15.9%; 
p = 0.06) of estrone 
sulfate. 30 g of
alcohol/day
resulted in an
increase of 10.7% 
(95% CI:
2.7 to 19.3%; 
p = 0.009) 
estrone sulfate
15 g of alcohol/day
resulted in an
increase of 5.1% 
(95% CI: 1.4 to 
9.0%; p = 0.008) 
DHEAS. 30 g of
alcohol/day
resulted in an
increase of 7.5% 
(95% CI: 3.7 to 
11.5%; p <0.001) 
DHEAS
Results suggest 
a possible 
mechanism by
which 
consumption of
one or two 
alcoholic drinks
per day by
postmenopausal
women could 
increase their
risk of breast 
cancer.
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Study Model Study Design Mechanism Examined
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as
Reported by
Study Authors
Ginsburg et al. 
1996
88 
12 postmenopausal
women receiving
oral estrogen
(estradiol, 
1 mg/day) and 
progestin 
(medroxy­
progesterone
acetate) 
replacement 
therapy were 
compared with 
12 postmenopausal
women who were
not using estrogen 
replacement 
therapy (ERT).
Randomized, 
double-blind, 
placebo-
controlled
crossover study
Effects of alcohol
ingestion on estrogens in 
postmenopausal women
Pineapple juice 
and 40% ethanol
at a dose of 
2.2 mL/kg of
body weight 
(0.7 g/kg of body
weight) in a total
volume of
300 mL over 
15 minutes
Within 50 minutes
of alcohol ingestion 
in postmenopausal
women on ERT, 
there was a 
3-fold increase in 
estradiol levels
from 297 to 
973 pmol/L
(p <0.001)
No changes in 
estradiol following
alcohol ingestion in 
postmenopausal
women not on ERT
Acute alcohol
ingestion may
lead to 
significant and 
sustained 
elevations in 
circulating
estradiol.
Ginsburg et al. 
1995
87 
14 menopausal
women using
transdermal
estradiol
Two randomized
crossover 
studies
Effect of acute ethanol
ingestion on prolactin in 
menopausal women
using estradiol
replacement
Ethanol (1 mL/kg, 
95% ethanol)
over 20 minutes
Alcohol when 
compared to
isocaloric
carbohydrate drink
ingestion resulted
in increased serum
prolactin levels in 
both study 1 
(p <0.03) and study
2 (p <0.001)
There was an
increase in 
serum prolactin 
levels.
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Study Model Study Design Mechanism Examined
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as
Reported by
Study Authors
Reichman et al.
1993
86 
34 premenopausal
women with a 
history of regular 
menstrual cycle
Randomized, 
diet-controlled
crossover 
intervention
The effects of alcohol
consumption on plasma 
and urinary hormone 
(DHEA, estrogens)
concentrations in 
premenopausal women
30 g of ethanol
daily for three
menstrual cycles
and no alcohol
for the other 
three
Plasma DHEAS
levels increased by
7.0% (p = 0.05) in 
the follicular phase
Plasma estrone 
levels increased by
21.2% (p = 0.01) in 
the peri-ovulatory
phase
Plasma estradiol
increased by 27.5% 
(p = 0.01), urinary
estradiol increased 
by 31.9%
(p = 0.009) in the
peri-ovulatory
phase
At the luteal phase, 
urinary estrone
increased by 15.2% 
(p = 0.05), estradiol
levels increased by
21.6% (p = 0.02), 
and estriol levels
increased by 29.1% 
(p = 0.03)
Results suggest 
a possible 
mechanism
between alcohol
consumption
and risk of
breast cancer.
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Table C-2. Summary of results from animal studies on breast cancer
Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Hilakivi-Clarke 
et al. 2004
92 
Elevated levels of
estrogen
receptors
Rats Amount in study
groups:
0 g/kg ethanol
vs. 
16 g/kg ethanol
vs. 
25 g/kg ethanol
Duration of Exposure:
12 days
Dimethylene(a)anthra 
cene (DMBA)
Latency to the 
appearance of first 
tumor [weeks, mean 
([s.e.m)] was 9.7 (0.6) 
in the control, 8.4
(0.5) in the 16 g 
alcohol group, and 
8.6 (0.5) in the 25 g
alcohol group.
Tumor incidence and 
tumor multiplicity were 
higher in the alcohol
groups compared to 
control.
Tumor growth rate 
was similar in all three 
groups.
Maternal alcohol intake 
increased offspring’s
mammary tumorigenesis.
Castro et al.
2003
95 
Biotransformation 
of ethanol to 
acetaldehyde
Rats Amount in study group:
0.21M ethanol
Duration of exposure:
1 hour
None Biotransformation of
ethanol to 
acetaldehyde 
occurred in mammary
tissue microsomes.
Result could have a 
significant effect in some 
stages of the process of
breast tumor promotion by
ethanol.
Chhabra et al. 
2000
96 
Formation of DNA
adducts
Rats Amount in study group:
1.6 g/kg ethanol
Duration of exposure:
14 days
N­
nitrosodimethylamine 
(NDMA),
4­
(methylnitrosamino)­
1-(3-pyridyl)-1­
butanone (NNK)
There was a 10-fold 
increase in O
6 
-
methylene adducts
from NDMA in 
mammary gland 
following cotreatment 
with ethanol.
Nitrosamines and ethanol
are contributors to mammary
cancer risk and perinatal
carcinogenesis.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Watabiki et al. 
2000
97 
Ethanol-induced 
hyperprolactinemia
and/or mammary
tumor virus
increased by the 
hyperprolactinemia
Rats Amount in study
groups:
10% ethanol
vs.
15% ethanol
vs.
tap water
Duration of exposure:
25 months
None In the ethanol-treated 
group, tumor 
occurrence was
reported in 9 (45%) of
the 20 rats at 8 to 
24 months. There no
occurrence of tumor in 
the control.
The murine model may be 
useful to study the role of
ethanol in mammary
tumorigenesis.
Holmberg et al.
1995
91 
None reported Rats Amount in study
groups:
1 ethanol
vs.
3% ethanol
Duration of exposure:
2 years
None Following the 
administration of low 
amounts of ethanol, 
there was an increase 
in mammary gland 
fibroma, 
fibroadenoma or 
adenoma.
The finding seems not to be
consistent in terms of a 
dose-response relationship 
or in their interrelation and 
may thus be regarded as an 
unspecific phenomenon.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Singletary et al.
1995
93 
Influence on
initiation and 
promotion stages
of carcinogenesis
through change in 
blood estrogen
and progesterone
Rats Amount in study
groups:
Diet containing ethanol
at 0% calories
vs.
15% calories
vs.
20% calories,
vs.
30% calories
Duration of exposure:
22 days
N-methyl-N­
nitrosourea (MNU)
Ethanol consumption 
at 15% caloric intake 
resulted in an
increase during either 
the initiation or
promotion stages.
Ethanol consumption 
at 20% caloric intake 
resulted in increase
during the promotion 
stage
There was no effect 
on either stage in the
group that received
ethanol at 30% caloric
intake.
Ethanol at specific intakes
can enhance the initiation 
and promotion stages of
MNU-induced mammary
tumorigenesis. However, 
there was not a consistent 
and proportionate increase 
in mammary tumor
development with increasing 
intakes of ethanol.
Singletary and
McNary 1994
94 
Effect on serum
estradiol and
progesterone 
Rats Amount in study
groups:
Diet containing ethanol
at 0% calories
vs.
20% calories, 
vs.
30% calories
Duration of exposure:
35-39 days
MNU Ethanol consumption 
at 20% caloric intake 
resulted in a 
19% increase in 
rat mammary gland 
terminal-end bud 
(TEB) density and
49% decrease 
in alveolar bud (AVB)
structures.
Ethanol consumption 
at 30% caloric intake 
resulted in a 
45% increase in 
rat mammary gland 
TEB density and
44% decrease in AVB
structures.
Ethanol consumption can 
lead to an increase in the
quantity of and the rate of
cell proliferation of
mammary gland terminal-
end bud (TEB) structures.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Taylor et al.
1993
99 
Suppression of
cellular immunity
(T cell activation 
and proliferation, 
and on natural
killer [NK] 
cytotoxicity)
Rats Acute ethanol exposure 
of 2.5-3.5 g/kg 
body weight 
1 hour before tumor 
inoculation
vs.
chronic consumption of
liquid diet containing 
ethanol for 2 weeks
before and for 3 weeks
after tumor inoculation.
Study authors only
reported 
“Tumor inoculation” 
by MADB106
Blood NK cytotoxic
activity was reduced 
in ethanol treated rats.
Number of blood large 
granular lymphocytes
(LGL) per NK cells at 
2 hours post ethanol
administration 
dropped to 86% of
control group and at 
5 hours post ethanol
administration: 
dropped to 74% of
control group.
Alcohol exposure during 
fetal or adult life has
profound
immunopathological effects.
McDermott et
al. 1992
101 
The aim of the 
study was to test 
the hypothesis
that dietary
alcohol intake 
increases the 
incidence of
experimental
mammary
carcinoma
Rats Amount in study
groups:
4.4 g/kg/day ethanol
vs. 
tap water
Duration of exposure:
10 days
DMBA Mean time (days, [SD] 
to first tumor 
appearance in the
alcohol group was
63 (16.3) and 
67.3 (19) in the
control.
Mean number of
tumors/animal in the
alcohol group was
3.2 (2.2) and 2.9 (2.7)
in the control.
Tumor rate growth 
(mm3/day) in the
alcohol group was
30.7 (17.7) and
25.5 (11.8) in the
control.
This study failed to support 
the hypothesis that dietary
alcohol intake increases the 
incidence of mammary
carcinoma.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Hackney et al. 
1992
102 
Enhancement of
the rate of
mammary tumor 
development
Rats Amount in study
groups:
4 g/kg/day ethanol
vs.
15 g/kg/day ethanol
vs.
20 g/kg/day ethanol
Duration of exposure:
65 weeks
None There was
no difference among 
study groups
(p = 0.10) in 
development of
mammary tumors.
Findings do not support the
hypothesis that ethanol
augments the risk of breast 
cancer.
Singletary and
McNary
1994
104 
Effect on 
mammary gland 
structural
development, 
DNA synthesis, 
and decrease in 
serum
progesterone
Rats Amount in study
groups:
Diet containing ethanol
at 0%
vs.
15%
vs.
20%
vs.
25% of calories
Duration of exposure:
Experiment 1: 32 days
Experiment 2: 28 days
Experiment 3: 33 days
None In experiment 1, TEB
increased for rats fed 
ethanol at 20% and 
30% caloric intake 
and density of AVB 
decreased at all
ethanol
concentrations.
In experiment 2, TEB
density of ethanol-fed 
rats increased 64%.
In experiment 3, there 
was no change in 
serum estradiol. 
However, serum
progesterone: 
decreased by 56% 
and 51% compared to
pair-fed control and
ad lib-fed control rats, 
respectively.
Cancer risk in humans may
be proportional to both cell
number and rate of cell
division within a target 
tissue.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Singletary et 
al. 1991
105 
Effect on 
mammary gland 
structural
development and 
DNA synthesis
Rats Amount in study
groups:
Diet containing ethanol
at 0%
vs.
15%
vs.
20%
vs.
30% of calories
Duration of exposure:
29 days
DMBA Rats that consumed 
ethanol at 10% and 
20% of calories
exhibited a significant 
increase in TEB
density and a 
significant decrease in 
AVB density.
Rats that consumed 
ethanol at 20% of total
calories prior to 
DMBA administration 
exhibited a significant 
54-74% increase in 
tumor incidence 
compared with rats
fed the control diet.
78%, 82%, and 91% 
of tumor-bearing rats
possessed 
adenocarcinomas for 
rats fed the diets
containing 0%, 10%, 
and 20% of calories
as ethanol, 
respectively. 
For rats fed ethanol at 
30% of calories, tumor 
incidence was
identical to that for 
rats fed the control
diet until 12 weeks
following DMBA
dosing.
Specific quantities of ethanol
can enhance the initiation 
and the promotion stages of
DMBA-induced mammary
tumorigenesis.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Rogers and
Conner
1990
100 
Enhancement of
carcinogenesis
Rats Amount in study
groups:
Diet providing 10%
vs.
20%
vs.
50% of calories as
ethanol
Duration of exposure:
Exp 1: 10% of ethanol
for 1 week, 
20% of alcohol for 
3 weeks.
Exp 2: 10% of ethanol
for 4 days, 20% for the 
remainder of the 
experiment.
Exp 3: 10% of ethanol
for 4 weeks, at the 
beginning of the 
4th week the rats were 
given a single dose of
50% ethanol.
DMBA In all experiments, 
there was
no detectable effect 
on mammary tumor 
latency, incidence, 
number, weight or
histology.
There was no effect of
ethanol on mammary gland 
tumorigenesis induced by
DMBA.
Grubbs et al. 
1988
103 
Enhancement of
mammary cancer 
initiation
Rats Amount in study
groups:
7.0 g/kg ethanol
vs.
3.5 g/kg ethanol
Duration of exposure:
DMBA group: 3 weeks
MNU group: 8 weeks
DMBA
MNU
Mammary cancer 
initiation by DMBA
was increased by both
dose levels of ethanol.
Mammary cancer 
initiation by MNU was
increased by high 
dose of ethanol.
Ethanol enhances mammary
cancer initiation.
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Study
Mechanism 
Examined Experimental Model
Amount and Duration
of Ethanol and/or 
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as Reported
by Study Authors
Schrauzer et 
al. 1979
98 
Change in 
prolactin levels
Mice Amount in study
groups:
12% ethanol
vs.
table wine with an
alcohol content of
11.5%
Duration of exposure:
6 weeks
Bittner virus Mean serum prolactin 
levels (ng/ml [SD]) in 
the alcohol group was
23 (9) and 52 (23) in 
the control.
Tumor incidence, 
growth rates and
latency in the alcohol
group occurred in 
8 animals that
developed
adenocarcinoma, the 
first at the age of
6 months
(after 5 months of
exposure), the last 
at 11 months
(median: 8). The 
tumor incidence was
73%.
Among the control, 
animals developed
mammary tumors
between 12 and 
16 months of age
(median: 14.2). Tumor 
incidence was 82%
* difference in latency
times was
significant 
(p <0.001)
Long-term exposure to 
ethanol significantly reduced 
the latency period in the
genesis of spontaneous
mammary adenocarcinoma.
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Table C-3. Summary of results from cell line studies on breast cancer
Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Etique et al. 
2009
106 
Cross-talk between 
A2A Adenosine 
receptor (A2A AR) and
the estrogen receptor-
alpha
MCF-7 Amount in study
groups:
0.3% ethanol
vs.
0.1% ethanol
Duration of
exposure:
24 hours
There was an increase in the
level of progesterone receptor 
mRNA following 24 hours of
treatment with 1uM CGS21680 
(a selective agonist). Antagonist 
(MSX-3) induced a dose-
dependent inhibition of an 
ethanol-induced increase in
progesterone receptor
expression.
Although results demonstrate 
cross-talk between A2A AR and 
estrogen receptor-alpha in the
ethanol action on MCF-7 cells, 
the link between ethanol and 
A2A AR remains to be 
determined.
Venkata et al. 
2008
115 
Relationship between
ethanol and its
metabolite 
acetaldehyde on 
peroxisome 
proliferator-activated 
receptor (PPAR)alpha 
and PPAR(beta)
transactivation
MCF-7 Amount in study
groups:
0 mM ethanol
vs.
10 mM ethanol
vs.
30 mM ethanol
vs.
100 mM ethanol
vs.
300 mM ethanol
Duration of
exposure:
24 hours
Over a range of ethanol
concentrations up to 300mM, 
ethanol was able to dose 
dependently and significantly
increase the expression of
PPAR(alpha) mRNA in MCF-7 
cells. Ethanol also modestly
increased the mRNA for 
PPAR(beta) with a significant 
increase seen at 30 and 300mM, 
although not at 100mM. The 
increased expression for 
PPAR(beta) mRNA was only in 
the order of two-fold in contrast to
the approximately sevenfold 
increase seen for PPAR(alpha) 
compared with the absence of
ethanol.
There is likely to be a complex
interplay in the way ethanol
and/or acetaldehyde acts via the
PPARs and other proteins to 
influence tumorigenic relevant 
pathways such as proliferation,
resistance to apoptosis, and 
invasiveness.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Etique et al. 
2007
68 
Activation of the 
estrogen signaling
pathway (cyclic AMP
[cAMP]/protein kinase 
A [PKA]).
MCF-7 Amount in study
groups:
0.1% ethanol
vs.
0.3% ethanol
vs.
0.5% ethanol
vs.
0.7% ethanol
Duration of
exposure:
24 hours
There was a significant 1.6-fold 
increase in progesterone receptor 
mRNA level for either 0.1 or 0.3% 
ethanol and a 1.3-fold increase in
pS2 expression for a dose of
0.3%.
Ethanol treatment of MCF-7 
breast cells stimulates the 
cAMP/PKA pathway which 
triggers two important events: an 
increase in the expression of
genes with cAMP response
element (CRE) in their promoter, 
like aromatase as well as a
ligand-independent activation of
estrogen receptor-alpha and 
transcription of target genes.
Etique et al. 
2004
65 
Stimulation of cell
proliferation, estrogen
receptor-alpha, and 
aromatase expression
MCF-7 Amount in study
groups:
0.0% ethanol
vs.
0.1% ethanol
vs.
0.3% ethanol
Duration of
exposure:
Up to 6 days
Ethanol enhanced cell
proliferation and clonal growth of
MCF-7 cells. In the presence of
0.1% ethanol, there was a
significant increase in cell
proliferation (11.5%) at day 4 and 
it peaked at 28% at day 6. In the
presence of 0.3% ethanol, there 
was a significant increase (11%)
at day 4, and no significant
change at day 6.
Study supports data suggesting
that ethanol is an increased risk
factor for breast cancer.
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Amount and
Duration of
Ethanol and/or
Experimental Acetaldehyde Conclusions as Reported by 
Study Mechanism Examined Model Exposure Results Study Authors
Izevbigie et al. Disruption and
51
2002 modulation of cell
proliferation
MCF-7 Ethanol (0.1%­
10%) with or 
without an
inhibitor of
mitogen activated
protein kinase 1
vs.
0.3%, 3%, and
10% ethanol for 
5-, 10-, 20-, and
40-min time 
course 
experiments.
Exposure of to 65 mM (0.3% 
ethanol) increased incorporation 
of [3-H] thymidiene into MCF-7 
cells by approximately two-fold 
over control. In contrast to the
growth stimulatory effect of
0.3% ethanol, both 3% and 10% 
ethanol significantly inhibited 
cell growth.
Ethanol stimulates p44/42
mitogen-activated protein 
kinase’s activity and subsequent 
MCF-7 cell proliferation.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Przylipiak et al.
1996
110 
Direct growth­
stimulatory effect on 
cancer cells by
enhancement of
3H-thymidine
MCF-7 Amount in study
groups:
0.00001%
ethanol
vs.
0.0001% ethanol
vs.
0.001% ethanol
vs.
0.01% ethanol
vs.
0.1% ethanol
vs.
1% ethanol
vs.
10% ethanol
Duration of
exposure:
5 hours
Ethanol enhanced 3H-thymidine
uptake in cultured human
mammary carcinoma cell line
MCF-7. The most effective 
concentration was 0.01% which 
evoked a 202% enhancement of
3H-thymidine uptake, when
compared to controls. 
Concentrations of ethanol
between 0.0001% and 10%
also significantly enhanced
3H-thymidine uptake. 
A concentration of 0.00001% 
ethanol did not affect thymidine 
incorporation.
Ethanol appears to play a role in 
tumor promotion in vivo as a 
result of direct growth­
stimulatory effect on human 
mammary cancer cells in vitro.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Singletary et
al. 2004
107 
Decreased capacity to 
remove benzo[a]pyrene 
diolepoxide-DNA
(BPDE-DNA) adducts
MCF-10F Amount in study
groups:
0 mM ethanol
vs.
15 mM ethanol
vs.
25 mM ethanol
Duration of
exposure:
48 hours
Incubation of cells with ethanol
was associated with a significant 
increase in prevalence of BPDE­
DNA adducts compared to
controls.
Ethanol- and oxidative stress-
associated inhibition of
carcinogen-DNA adduct removal
in non-neoplastic human
mammary cells may be another
biological mechanism to explain 
the increased risk for breast 
cancer among women
consuming alcohol.
Barnes et al. 
2000
108 
DNA adduct formation
and enhancement 
carcinogen-induced
DNA damage in target 
cell DNA
MCF-10F Amount in study
groups:
Ethanol: 0, 5, 15, 
or 25 mM
vs.
Aldehyde: 0, 0.5,
2.5, or 5.0 µM
Duration of
exposure:
6 days
Exposure of cells to
physiologically relevant 
concentrations of either ethanol
or aldehyde prior to dosing with 
B[a]P increased adducts
formation.
A possible mechanism by which 
alcohol intake may be
enhancing breast cancer risk in 
humans may be through an
ethanol- and aldehyde-
associated increase in 
carcinogen-DNA adducts in the 
target mammary epithelial cells.
Zhu et al.
2001
109 
Modulation of
expression of
ribosomal protein L7a
(rpL7a)
T4TD Amount in study
groups:
100-400 mg/dl
ethanol
Duration of
exposure:
16 days
Long-term exposure to ethanol
(2 weeks) significantly reduced
the transcript of rpL7a by more 
than 60%.
Ethanol-induced alteration of
rpL7a expression may mediate
the promoting effects of ethanol
on breast cancer development.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Dhar and 
Plummer 
2006
112 
Protein expression of
G-protein inwardly
rectifying potassium
channels (GIRK)
MDA-MB-453 Amount in study
group:
0.12% ethanol
Duration of
exposure:
16 hours
Transfection of GIRK1 or GIRK4 
plasmids decreased gene 
expression in MDA-MB-453
breast cancer cells.
Functional GIRK channel exists
in breast cancer cells that are 
involved in cellular signaling.
Singletary et
al. 2001
69 
Proliferation and
intracellular content of
cAMP in estrogen 
receptor (ER)-alpha 
expression
MCF-7, 
ZR75.1,
BT-20, 
MDA-MB-231
Amount in study
groups:
0-100 mM 
ethanol
Duration of
exposure:
Up to 10 days
Exposure of ER+ cell lines to 
increasing concentrations of
ethanol was associated with an 
increase in cell proliferation.
For example, ethanol added to 
cultures of cells at concentrations
of 20-50 mM significantly
stimulated proliferation of MCF-7 
and ZR75.1 cells by 53-91% 
following 7 and 10 days of
treatment, compared to controls.
Treatment with ethanol is
associated with increased
proliferation of two estrogen 
receptor-positive human breast 
cancer cell lines.
Zhu et al.
2001
114 
Up-regulation of
transcription of smooth 
muscle myosin alkali
light chain (MLC 1sm)
MCF-7, T47D, 
MDA-MB-231
Amount in study
groups:
50-400 mg/dl
ethanol
Duration of
exposure:
16 days
At 400 mg/dl, an ethanol-
mediated increase was evident at 
6 hours (55% increase), peaked
at 24 hours (2.7 fold increase) 
following exposure.
At pharmacologically relevant 
concentrations (e.g., 100 mg/dl), 
ethanol produced a significant 
increase of MLC 1sm expression, 
and progressively higher ethanol
concentrations resulted in more 
up-regulation.
Alcohol consumption may
promote the progression of
breast cancer in women.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Fan et al.
2000
67 
Stimulation of the 
estrogen receptor 
signaling
MCF-7, T47D Amount in study
groups:
60 mM-100 mM 
ethanol
Duration of
exposure:
24 hours
Alcohol partially reverses the 
BRCA1-mediated inhibition of
estrogen receptor-alpha
transcriptional activity. Alcohol
down-regulates BRCA1 and up-
regulates estrogen receptor-alpha 
expression in MCF-7 cells.
Inactivation of BRCA1 and
increased estrogen-
responsiveness might contribute 
to alcohol-induced breast 
cancer.
Verna and 
Davidson
1999
113 
Mammary gland mucin 
(MUC1) upregulation
MCF-7, T84 Amount in study
groups:
0 mM ethanol
vs.
50 mM ethanol
vs.
100 mM ethanol
vs.
150 mM ethanol
vs.
200 mM ethanol
vs.
250 mM ethanol
vs.
500 mM ethanol
Duration of
exposure:
Acute exposure: 
24 hours
Chronic
exposure: up to 
4 weeks
Ethanol enhanced the expression
of MUC1 mRNA in a dose- and 
time-dependent manner in MCF-7 
cells.
Ethanol regulates expression of
the MUC1 gene at the
transcription level which strongly
suggests the existence of
ethanol responsive elements in 
the promoter of the mucin gene.
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Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Results
Conclusions as Reported by 
Study Authors
Cyong et al. 
1978
111 
Increase cAMP levels MM46 tumor 
cells
Amount in study
groups:
0%
vs.
0.1%
vs.
0.5%
vs.
1.0%
vs.
2.5%
vs.
5.0% ethanol
Duration of
exposure:
30 minutes
Dose-related increases in cAMP
were observed at ethanol
concentrations from 0.1% to 
5.0%.
Results suggest that either
tumor cell membrane, or its
membrane-associated defense
mechanism for detergents, 
may be incomplete.
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Evidence Base for Colorectal Cancer
Table C-4. Summary of results from human studies on colorectal cancer
Study
Amount and
Duration of Ethanol Conclusions 
Mechanism and/or Acetaldehyde as Reported by
Study Design Examined Exposure Results Study Authors
Case series.Basuroy et al. The effect of Biopsies were exposed Acetaldehyde These may have 
83
2005 acetaldehyde on to vapor-phase resulted in epithelial significant Mucosal biopsies
tyrosine acetaldehyde, to TJ disruption by implications for the from the left 
phosphorylation, achieve acetaldehyde inducing tyrosine loss of cell-cellcolon (4 forceps
immmunofluorescence concentration of phosphorylation and adhesion andbiopsies from
localization, and 100-600 uM in the dissociation from the increased risk for visibly normal
detergent-insoluble buffer bathing the cytoskeleton of TJ colon cancer.area of mucosa 
fractions of the tight tissue. Briefly, biopsies and AJ proteins.in each subject)
junctions (TJ) and in 24-well culture plateswere collected 
adherens junctions were treated with from subjects
(AJ). vapor-phase admitted for 
acetaldehyde bycolonoscopy for 
placing stockthe purpose of
acetaldehyde solutioncancer 
(0.1%-0.6%) in thesurveillance.
reservoir wells and 

Authors did not 
 sealing the lid to the
 
report patients’
 plate with tapes.
 
characteristics
 
5 hoursand previous
 
alcohol exposure.
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Table C-5. Summary of results from animal studies on colorectal cancer
Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Hayashi et al.
2007
118 
Increased
expression of
cytochrome 
P4502E1
(CYP2E1)
Rats Amount in study
group:
Ethanol-containing
liquid diet (36% of
total calories, 
5% ethanol v/v)
Duration of
exposure:
36 weeks
1,1-dimethylhydrazine
(DMH)
The number of
aberrant crypt foci
(ACF) in colons
obtained from ethanol-
fed rats with DMH was
24, which was
significantly more than 
that of the other
treated rats.
The increased
expression of CYP2E1
induced by chronic
ethanol consumption
promotes
the development of
DMH-induced colon
cancer.
Perez-Holanda
et al. 2005
73 
Effect of ethanol
consumption on
experimental colon 
carcinogenesis
using a dynamic
model with
concomitant 
administration of
alcohol and 
dimethylhydrazine 
(DMH).
Rats Amount in study
group:
Ethanol at a dose 
of 1.23 g/kg of
body weight 
Duration of
exposure:
24 weeks
DMH Tumors developed 
only in DMH treated
groups: 25 rats (89%)
in the DMH group and 
16 rats (100%) in the 
DMH + ethanol group. 
However, when
excluding tumor-free
animals, 
no differences were 
observed in the mean 
number of tumors per
rat (1.67 in the DMH 
group compared to 
1.60 in the DMH +
ethanol group).
Addition of an ethanol
supplement does not 
modify colorectal
carcinogenesis using a 
dynamic model of
tumor induction with 
DMH.
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Amount and
Duration of
Conclusions asEthanol and/or
Mechanism Experimental Acetaldehyde Reported by Study
Study Use of Carcinogen ResultsExamined Model Exposure Authors
Pronko et al. Activities of Rats Amount in study None MEOS activity in the This mechanism can
2002
120 
alcohol
dehydrogenase 
(ADH), catalase, 
microsomal
ethanol-oxidizing
system (MEOS), 
and aldehyde
dehydrogenase 
(ALDH)
group:
Ethanol as 25% of
calories
Duration of
exposure:
35 days
alcohol group was
149% higher 
compared to control
group (increase not 
statistically significant).
Effect of acute alcohol
intoxication in rats
consuming ethanol
chronically (control vs. 
ethanol diet) as
measured by ethanol
concentrations in the
colon was 9.1 (0.98) 
vs. 11.1 (1.52) and in 
the rectum was 13.6
(2.57) vs. 17.9 (2.90).
Effect of acute alcohol
intoxication in rats
consuming ethanol
chronically (control vs. 
ethanol diet) as
measured by
acetaldehyde 
concentrations in the
colon was 7.93 (1.22)
vs. 18.5 (3.94)* and in
the rectum: 18.1 (3.95)
vs. 30.5 (7.13).
*p <0.05
account for the local
toxicity of ethanol after 
its chronic
consumption, and
relates the
development of
mucosal damage and
compensatory hyper-
regenerative 
processes, and
possibly
carcinogenesis, in the
colonic and rectal
mucosa of alcoholics to
the effects of
acetaldehyde.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Homann et al.
2000
70 
Folate deficiency
via microbial
acetaldehyde 
production
Rats Amount in study
group:
3 g/kg of ethanol
Duration of
exposure:
2 weeks
None Alcohol treatment led
to very high 
intracolonic
acetaldehyde levels
(387 [185] mM).
Erythrocyte, serum
and small intestinal
folate levels were 
unaffected by alcohol
treatment.
Alcohol administration
decreased significantly
colonic mucosal folate
levels by 48%.
Alcohol administration
leads to local folate
deficiency of colonic
mucosa in rats, most 
probably via the
degradation of folate by
the high levels of
acetaldehyde 
microbially produced
from ethanol.
Choi et al.
1999
124 
DNA methylation
and methylation of
p53 tumor 
suppressor gene
Rats Amount in study
group:
Diet containing
36% of total
energy as ethanol
Duration of
exposure:
4 weeks
None Titrated methyl uptake 
by colonic DNA from
alcohol-fed rats was
57% less than that in 
control DNA (p <0.05)
Genomic
undermethylation of
colonic DNA was
observed in the
alcohol-fed rats
compared to control
rats.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Hakkak et al.
1996
119 
The effects on
expression of
CYP2E1 and 
CYP2C7
Rats Amount in study
groups:
8-13 g/kg/day
ethanol. 
Duration of
exposure:
Not reported by
authors.
None CYP2E1 was found to
be present in the colon
and induced by
ethanol. Chronic
ethanol treatment 
increased expression 
of both hepatic
(p <0.01) and colonic
(p <0.05) CYP2E1 by
three-fold.
CYP2E1 and CYP2C7 
are present in the 
colonic tissue and are 
inducible by ethanol.
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Amount and
Duration of
Conclusions asEthanol and/or
Mechanism Experimental Acetaldehyde Reported by Study
Study Use of Carcinogen ResultsExamined Model Exposure Authors
Simanowski et Effect on rectal Rats Amount in study None While age by itself Hyperregeneration of
al. 1994
125 
cell proliferation 
(hyperregeneration)
group:
36% of total
calories as
ethanol, with an 
additional acute 
intraperitoneal
dose of 2.5 g/kg 
body weight
Duration of
exposure:
4 weeks
did not affect colorectal
cell renewal, chronic
ethanol consumption 
stimulated rectal, but
not colonic, crypt cell
production rate in an 
age dependent 
manner. While no
significant effect of 
ethanol was noted in
young animals, cell
proliferation was
significantly enhanced
in middle aged animals
by 81% (95% CI: 4.1 
(2.7-5.5) v 7.4 (6.0-8.7) 
cells/crypt/hour, 
p <0.001) and in 
old animals by 138%
(95% CI: 4.5 (3.3-5.6) v
10.7 (8.9-12.4)
cells/crypt/hour, 
p <0.001), after
ethanol ingestion.
There was a 
significant positive 
correlation between
crypt cell production
rate and acetaldehyde 
concentrations
measured in the distal
and proximal colon 
after an acute dose of
ethanol.
the rectal mucosa after 
alcohol drinking could
by itself favor 
carcinogenesis, which 
is especially relevant in 
old age.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Niwa et al.
1991
126 
Hyperproliferation 
of rectosigmoidal
colon
Rats Amount in study
groups:
7.5% ethanol
vs.
10% ethanol
vs.
15% ethanol
Duration of
exposure:
414 days
Methylazoxymethanol
(MAM) acetate
Incidence of colonic
cancer (11/17, 85%)
was higher in the
group that received
10% ethanol
compared to control
distilled water, 
p = 0.04.
A relatively short-term
administration of
ethanol induced 
significant 
hyperproliferation of the 
colonic, especially
rectosigmoidal colonic,
mucosa.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Seitz et al.
1990
122 
Acetaldehyde 
generation
Rats Carcinogenesis
Study 1 with a
duration of
exposure of
15 weeks:
Liquid diet 
containing 36% of
total calories as
ethanol
vs.
isocaloric glucose
Carcinogenesis
Study II with a
duration of
exposure of 3 hrs:
2.5 ml 0.15 NaCl
vs.
2.5 ml 0.15 NaCl +
cyanamide (CY)
vs.
2.5 ml ethanol
vs.
2.5 ml ethanol +
CY
Acetaldehyde 
Determination in 
Blood and
Tissues:
Acute dose of
ethanol (2.5 g/kg 
body wt)
Acetoxymethyl­
methylnitrosamine
(AMMN)
CY
Using metaphase-
arrest technique, 
administration of
alcohol induced rectal
(99.1 [2.0] vs. 9.1 [1.8] 
cells/crypt/hour, 
p <0.01), but not 
caecal (18.9 [1.3] vs. 
22.2 [3.3]] 
cells/crypt/hour, 
p <0.05.
Mucosal concentration 
of acetaldehyde
(nmolg/colon)* in the
rectum was 198 (23)
and 120 (23) in the 
caecum.
These values were
not affected by
chronic alcohol
feeding.
*p <0.05
Chronic ethanol
consumption can
stimulate under certain 
experimental conditions
chemically induced
rectal carcinogenesis
by direct mechanisms
in the rectal mucosa, 
possibly mediated by
acetaldehyde.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
McGarrity et al. 
1988
129 
Changes in 
polyamine content
Rats Amount in study
group:
Ethanol as 36% of
total calories
Duration of
exposure:
16 weeks
DMH DMH and
DMH + ethanol groups
developed 
20 adenocarcinomas: 
with tumors located in 
the proximal colon
(8 vs. 3), distal colon
(11 vs. 114) and 
rectum (1 vs. 3) for the 
DMH and
DMH + ethanol
groups, respectively. 
No tumors developed
in the control or 
ethanol treated
groups.
Chronic ethanol
consumption did not 
alter overall tumor 
formation, however 
consumption was
reported to increase 
putrescine content in 
all 3 regions (proximal, 
distal colon and
rectum) compared to
the control liquid diet
group. Increase in 
tissue putrescine levels
may possibly reflect 
increased ornithine
decarboxylase activity
which has been shown 
to be increased in 
human colon
adenocarcinomas and 
premalignant 
adenomas.
Hamilton et al. 
1988
130 
Effect on the
initiation phase of
carcinogenesis
Rats Amount in study
group:
Ethanol as 33% of
total calories
Duration of
exposure:
13 weeks
Azoxymethane (AOM) After 24 hours of
AOM administration, 
levels of DNA adducts
O
6 
-methylguanine and
7-methylguanine were 
reduced in the clonic
mucosa of the ethanol-
fed rats to 14 ±7% and
61 ±11% of controls.
Dietary ethanol during
the preinduction and 
induction phase of the
AOM model
dramatically inhibits
tumorigenesis.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Garzon et al.
1987
128 
Local effect of
ethanol on the
colorectal mucosa
Rats Amount in study
group:
Liquid diets
containing 36% of
total calories as
ethanol
Duration of
exposure:
10 weeks
AMMN Significant difference 
in occurrence of
colorectal tumors
following chronic
ethanol feeding at 
weeks 15 (42.1 vs. 
15.8, p <0.05). 
No significant 
difference was
reported at weeks 18
and 21.
Chronic ethanol feeding
combined with the 
direct acting carcinogen
AMMN resulted in an
earlier occurrence of
colorectal tumors.
Hamilton et al. 
1987
132 
Effect on fecal
bacterial flora, and 
colonic epithelial
DNA synthesis
Rats Amount in study
groups:
Liquid diet 
containing 0% 
ethanol
vs.
9% ethanol
vs.
18% ethanol as
calories
Duration of
exposure:
25 weeks
AOM Low ethanol group 
demonstrated a trend 
for higher incidence of
left-sided colonic
tumors compared to
controls (35% vs. 15% 
controls, p = 0.06). 
The total number of
tumors in the high-
ethanol group 
compared to controls
was 46% vs. 81%, 
p = 0.002), 
respectively.
Modulation of
experimental colonic
tumorigenesis by
ethanol consumption
was due to alcohol
rather than other 
beverage constituents.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Hamilton et al. 
1987
131 
Effect on 
preinduction, 
induction, and
postinduction
phases of
carcinogenesis
Rats Amount in study
groups:
Liquid diet 
containing
11% ethanol
vs.
22% ethanol
vs.
33% ethanol as
calories
Duration of
exposure:
13 weeks
AOM Suppression of colonic
tumorigenesis
occurred in the groups
with high levels of
chronic dietary ethanol
consumption during
acclimatization and 
AOM administration: 
in the 33% and 22% 
diet groups, the 
prevalence of colonic
tumors was 3% and
20% as compared with 
50% in control
(p <0.001 and p <0.02,
respectively).
Chronic dietary ethanol
effects on experimental
colonic tumorigenesis
with AOM are: 
(a) due to mechanisms
affecting the 
preinduction and/or 
induction phase, 
including carcinogen 
metabolism;
(b) unrelated to 
postinduction events
such as tumor 
promotion and 
progression; and 
(c) dependent on
ethanol dose with a
threshold for inhibition
of tumorigenesis which 
is mediated by ethanol
inhibition of carcinogen
metabolism.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Simanowski et
al. 1986
127 
Promotion of cell
proliferation
Rats Amount in study
group:
Liquid diet 
containing 36% of
total calories as
ethanol (6.6% v/v)
Duration of
exposure:
4 weeks
None Cell proliferation rate 
was 19.1 (2.0) in the
ethanol fed group vs. 
9.1 (1.8) 
cell/crypt/hour in the 
carbohydrate fed
group, p <0.005. 
Serum gastrin also 
was elevated in the
ethanol fed group 
172 (51) vs. 106 (27)
pmol/l, p <0.01).
The ethanol dependent 
proliferative changes in 
the rectal mucosa are 
predictive of higher 
susceptibility of this site 
to carcinogenesis, 
supporting
experimental and 
epidemiology data. 
Increased gastrin 
concentrations may
partly explain the
observed rectal
hyperproliferation. 
Other possible causes
cannot, however, be 
excluded.
Nelson et al.
1985
116 
None reported by
study authors
Rats Amount in study
groups:
95% laboratory
grade ethanol
diluted
vs.
tap water
Duration of
exposure:
19 weeks
DMH Number of colonic
tumors* in the DMH 
group was 77 and 88
in the DMH +
ethanol group.
*p = 0.764
No augmentation of
colonic tumor induction
in rats supplemented
by dietary ethanol was
seen.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Seitz et al.
1985
123 
Generation of
acetaldehyde
Rats Amount in study
groups:
Ethanol given as
36% of total
calories; ethanol
concentration of
alcohol diet was
6.6% (v/v)
vs.
isocaloric
carbohydrates
Duration of
exposure:
4 weeks
DMH There was a 2.8 fold 
increase in rectal
tumors on the ethanol
fed rats compared to
controls (p <0.02). 
All large intestinal
tumors were located in
the rectum in 47% of
ethanol fed rats vs. 
27% in controls.
The observed increase 
of ADH activity in the
distal colorectum after 
chronic ethanol feeding 
may be of relevance
with respect to the
cocarcinogenic effect of
ethanol in the rectum.
Howarth et al. 
1984
117 
None reported by
study authors
Rats Amount in study
groups:
High-fat diet
vs.
Beer
vs.
Alcohol (4.8% v/v)
Duration of
exposure:
20 weeks
DMH Alcohol did not affect 
the incidence of
intestinal cancers. 
The shift of mean 
tumor distance toward 
the anus was similar in 
ethanol drinkers
(0.61 [0.33] to
0.33 [0.23], p <0.05).
Alcohol had no effect 
in our syngeneic model
of DMH-induced
colorectal cancer, while 
a high-fat diet had a 
potent cocarcinogenic
effect.
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Study
Mechanism 
Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure Use of Carcinogen Results
Conclusions as
Reported by Study
Authors
Roy et al.
2002
121 
Effect on cell
proliferation, 
apoptosis, and
formation of
mutagenic
malondialdehyde­
acetaldehyde 
(MAA)
Mice Amount in study
group:
Ethanol
supplementation 
in the drinking
water (15% 
alternating with 
20% on a daily
basis)
Duration of
exposure:
10 weeks
None Ethanol
supplementation 
resulted in a significant 
increase in tumor 
number (135± 35%,
p = 0.027 vs. control). 
The induction of
tumorigenesis by
ethanol was most 
dramatic in the distal
small bowel
(167± 56%, p = 0.001).
Ethanol consumption is
a risk factor for 
colorectal cancer.
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Table C-6. Summary of results from cell line studies on colorectal cancer
Study
Mechanism 
Examined
Experimental 
Model
Amount and Duration of
Ethanol and/or Acetaldehyde 
Exposure Results
Conclusions as Reported by
Study Authors
Lemos et al.
2007
140 
Modulation of
folate uptake
Caco-2 Amount in study group:
12% alcohol
Duration of exposure:
Not reported
Ethanol had an acute inhibitory
effect on both 3H-folic acid and 
3H-methotrexate uptake.
Alcohol inhibited 3H-folic acid 
uptake in Caco-2 cells.
Rodriguez et al. 
2004
75 
Increase in 
tumor necrosis
factor-alpha 
receptor-1 
(TNF-R1)
levels
Caco-2 Amount in study groups:
25 mM ethanol
vs.
50 mM ethanol
vs.
100 mM ethanol
Duration of exposure:
48 hours
Caco-2 cells showed a 
significant 80% increase in 
TNF-R1 levels at 200 mM
ethanol (p <0.05).
Exposure of intestinal cells to 
pharmacologic concentrations of
ethanol increases TNF-R1 levels
and may augment TNF-alpha­
mediated cell injury.
Asai et al.
2003
134 
Intestinal
epithelial cell
death induced 
by acute, low 
concentrations
of ethanol
Caco-2 Amount in study groups:
0% ethanol
vs.
5% ethanol
vs.
10% ethanol
Duration of exposure:
3 hours
Treatment with 5% and 10% 
ethanol for 3 hours led to a 
gradual increase in
phosphatidylserine (PS)
externalization. Caspase­
mediated CK18 was
significantly enhanced as early
as 1 hour after 10% ethanol
incubation, while DNA
fragmentation was detected 
from 2 hours onwards.
Apoptotic cell death in confluent 
Caco-2 cells was induced by
acute and low concentrations of
ethanol. These results suggest 
that clinically achievable doses of
ethanol impair intestinal barrier 
function by induction of apoptosis
in intestinal epithelial cells.
Tong et al.
1999
74 
Induction of
epidermal
growth factor 
receptor
(EGFR)
expression and 
mitogenesis
Caco-2 Amount in study group:
0.22 mM of ethanol
Duration of exposure:
24 hours
Alcohol affects proliferation of
Caco-2 cells, elevates EGFR 
expression and raises cyclin 
D1 mRNA and protein 
expression.
Low blood levels of alcohol may
stimulate in vivo proliferation of
colonocytes by elevating 
transcription of a growth factor 
receptor as well as modifying
expression of a cell cycle 
regulator.
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Amount and Duration of
Mechanism Experimental Ethanol and/or Acetaldehyde Conclusions as Reported by
Examined Model Exposure Study AuthorsStudy Results
Koivisto and Effect of
Salaspuro 1998
136 
acetaldehyde 
alone or in 
combination 
with ethanol
on cell
proliferation 
rate
Caco-2 Study 1:
 
Acute exposure: 

cells were exposed to
 
acetaldehyde and/or ethanol
 
for 72 hours.
 
Study 2:
Chronic exposure: cells were
grown in the presence of
acetaldehyde and/or ethanol
for five passages with daily
change of media.
No significant differences were Ethanol-driven or even 
observed between the four endogenous acetaldehyde 
groups in the cytotoxic studies contributes to the initial steps of
(control vs. 100 mM ethanol vs. colonic carcinogenesis and has
500 uM acetaldehyde vs. an effect on later tumor 
1,000 uM acetaldehyde) development.
suggesting that a 72 hour 
treatment with 500 or 1,000 uM
acetaldehyde, or 100 mM
ethanol does not have 
cytotoxic effects on these cells.
In the proliferation studies, the 
acute effect of acetaldehyde on 
the proliferation rate of Caco-2 
cells was strongly inhibitory.
The duplication time of Caco-2 
cells was also significantly
increased by acute exposure to 
100 mM ethanol. Concomitant 
presence of ethanol did not, 
however, significantly alter the 
proliferation rate of
acetaldehyde-treated cells.
5-week treatment with 500 uM
acetaldehyde, both alone and 
in combination with 100 mM
ethanol, significantly
decreased cell duplication time 
as compared with control.
A 5-week treatment with 
100 mM alone did not have 
any significant effect on cell
proliferation rate.
Acetaldehyde decreased the 
adhesion of Caco-2 cells to 
both collagens 1 & IV in the
cell adhesion studies.
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Amount and Duration of
Mechanism Experimental Ethanol and/or Acetaldehyde Conclusions as Reported by
Examined Model Exposure Study AuthorsStudy Results
Koivisto and Effect of
Salaspuro 1997
137 
acetaldehyde 
on brush 
border enzyme 
activities
Caco-2 Amount in study groups:
 
500 uM acetaldehyde
 
vs.
 
500 uM acetaldehyde + 

100 mM ethanol
 
vs.
 
1,000 uM acetaldehyde +
 
100 mM ethanol
 
vs.
 
100 mM ethanol
 
Duration of exposure:
13 days
Ethanol alone significantly Acetaldehyde decreases the 
increased the specific activities activities of some, but not all, 
of sucrase and maltase, but brush border enzymes in Caco-2 
no significant effect on lactase cells.
activity.
Only ethanol increased alkaline 
phosphatase activity.
Control cells, as well as cells
grown in the presence of
100 mM ethanol alone or 
500 uM acetaldehyde, showed 
a typical pattern of dome 
formation, with a sharp 
increase in the number of
domes a few days after the 
confluency, followed by a rapid 
decrease and plateau. Cells 
grown in presence of both
100 mM ethanol and 1,000 uM
acateladehyde showed 
significantly fewer domes
4 and 7 days after the 
confluency than control cells.
The acetaldehyde 
dehydrogenase (ALDH) activity
of Caco-2 cells, measured 
using 200 uM acetaldehyde as
substrate was quite similar to 
that of normal colonic mucosa.
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Study
Mechanism 
Examined
Experimental 
Model
Amount and Duration of
Ethanol and/or Acetaldehyde 
Exposure Results
Conclusions as Reported by
Study Authors
Vaculova et al. 
2004
133 
Modulation of
the tumor 
necrosis factor 
(TNF)-related
apoptosis-
inducing ligand
(TRAIL)­
induced 
apoptosis
HT-29 Experiment 1:
4% ethanol alone or in 
combination for 4 or 24 h in the 
medium with 5% of fetal calf
serum (FCS).
Experiment 2:
Using ethanol (0.1–6%) alone, 
the cells were treated for 
48 hours.
There was only a limited 
cytotoxicity of TRAIL (100 
ng/ml) in HT-29 cells. After 
24-hour-treatment, the cell
viability was 82%. However, 
when TRAIL was combined 
with ethanol, only 40% of cells
remained viable.
There was no significant 
changes in ethanol-treated 
cells and about two-fold 
enhancement of the number of
cells with decreased MMP after 
TRAIL treatment (4 hours)
compared to control were 
detected.
Ethanol acts as a potent agent,
sensitizing colon cancer cells to 
TRAIL-induced apoptosis.
Blasiak et al.
2000
135 
Formation of
crosslinks with 
DNA
Colonic
mucosa (CM)
cells
Single exposure study: 
CM cells were exposed to 
ethanol at 10 mm
vs.
acetaldehyde at 100 mm for 
1 hour.
Combined exposure study: In 
combined exposure, the cells
were subsequently exposed to
ethanol and acetaldehyde at all
combinations of the 
concentrations of the agents
for 1 hour
Ethanol caused DNA strand 
breaks. The CM cells exposed 
to ethanol at 100 mM were 
able to remove DNA damage
within time period shorter than 
2 hours.
Alcohol consumption may lead to
the damage to DNA of
gastrointestinal tract, which in 
turn can directly or indirectly
contribute to the appearance and 
development of cancers of this
organ.
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Study
Mechanism 
Examined
Experimental 
Model
Amount and Duration of
Ethanol and/or Acetaldehyde 
Exposure Results
Conclusions as Reported by
Study Authors
Papavassiliou et al.
1994
139 
Modulation of
human 
leukocyte 
antigen (HLA)
class I gene 
expression
HT-29,
SW-1116, 
HCT-15
Amount in study group:
100% ethanol
Duration of exposure:
48 hours
Ethanol had no effect on the 
expression of HLA class 1 
antigens in human colon 
adenocarcinoma cell lines. 
Ethanol (1.7 x 10 
-10 
M to 1.7 x
10 
-1 
M), had no effect on the 
expression of HLA class 1 
antigens on these colonocytes, 
corresponding mRNA levels, or 
the expression of HLA
constructs.
These findings do not support the
hypothesis that ethanol may
modulate the expression of HLA
class 1 genes in human colon 
cancer cells.
Malagolini et al. 
1994
138 
Differentiation 
of intestinal
cells
Caco-2,
HT-29
Amount in study groups:
0 mM ethanol
vs.
50 mM ethanol
vs.
100 mM ethanol
vs.
200 mM ethanol
Duration of exposure:
7 days
The addition of ethanol in the
culture medium resulted in a 
significant increment of
sucrase and alpha 2, 
6-sialyltransferase activities in 
all cell lines, as well as the 
beta 1, 
4-N-acetylgalactosaminyl­
transferase activity in the
Caco-2 cells and alkaline 
phosphatase activity in
HT-29 cells.
Ethanol in vitro affects the 
differentiation of intestinal cells
along the enterocytic lineage.
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Table C-7. Summary of results from combination study (animal, cell line) on colorectal cancer
Study Mechanism Examined
Experimental
Model
Amount and
Duration of
Ethanol and/or
Acetaldehyde 
Exposure
Use of
Carcinogen Results
Conclusions as Reported by 
Study Authors
Pannequin 
et al. 
2007
141 
Accumulation of
phosphatidylethanol
resulting in a signal
change in intestinal cell
proliferation
Mice, Caco-2 Animal study:
2 mol/L (10%)
ethanol for 
4 months.
Cell line study:
10 mmol/L of
ethanol or 
0.5 mmol/L of
acetaldehyde 
once daily for 
48 hours.
None Chronic exposure 
to low doses of
ethanol
(10 mmol/L) 
induces an
increase of
maximal intestinal
cell density.
The disruption of cellular 
signals might facilitate the
stimulatory role of ethanol
metabolites such as
acetaldehyde on the 
proliferation of cells within 
intestinal crypts, thereby
participating in the well-
established cocarcinogenic
role of alcohol consumption in 
the colon.
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Appendix D: List of Excluded Studies
Table D-1. Excluded full articles
Study Reason(s) for Exclusion
Yi et al. 2010
313 
Cancer mortality study.
Author(s) not listed 1988
103 
Clinical meeting article.
Purohit et al. 2005
40 
Clinical meeting article.
Scheppach et al. 1999
314 
Clinical meeting article.
Seitz et al. 1992
315 
Clinical meeting article.
Weisburger 1992
316 
Clinical meeting article.
Kleinjans et al. 1996
317 
Contents of alcoholic beverage.
Potter et al. 1982
318 
Correlation analysis study.
Siegmund et al. 2003
319 
Description of animal models in gastrointestinal alcohol
research.
Aye et al. 2004
320 
Invasion of breast cancer cells.
Luo 2006
321 
Invasion of breast cancer cells.
Luo and Miller 2000
322 
Invasion of breast cancer cells.
Ma et al. 2003
323 
Invasion of breast cancer cells.
Meng et al. 2000
324 
Invasion of breast cancer cells.
McGarrity and Nelson 1986
325 
Letter to editor.
Larsen 1993
326 
News report publication.
Colombo et al. 2001
327 
No outcome of interest.
Fiala et al. 1987
328 
No outcome of interest.
Zedeck 1980
329 
No outcome of interest.
Holford 1987
5 
Pharmacokinetic study.
Weisburger and Wynder 1984
330 
Review article.
Agrawal et al. 2007
331 
Review article.
Alberts 2002
332 
Review article.
Ambrosone 2000
333 
Review article.
Arasaradnam et al. 2008
334 
Review article.
Author(s) not listed 2000
1 
Review article.
Author(s) not listed 2008
27 
Review article.
Author(s) not listed 1994
335 
Review article.
Baan et al. 2007
2 
Review article.
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Study Reason(s) for Exclusion
Bailey 2003
336 
Review article.
Blot 1992
337 
Review article.
Boffetta and Hashibe 2006
338 
Review article.
Bosetti et al. 2002
339 
Review article.
Brown 2005
340 
Review article.
Campos et al. 2005
341 
Review article.
Chhabra et al. 1996
342 
Review article.
Correa Lima and Gomes-da-Silva 2005
343 
Review article.
Dossus and Kaaks 2008,
344 
Review article.
Dumitrescu and Cotaria 2005
345 
Review article.
Ferguson et al. 2005
346 
Review article.
Filion 2002
347 
Review article.
Forman et al. 2004
348 
Review article.
Fraumeni 1979
349 
Review article.
Gago-Dominguez et al. 2007
350 
Review article.
Giovannucci 2002
351 
Review article.
Goodwin 2008
352 
Review article.
Hamid et al. 2009
353 
Review article.
Heavey et al. 2004
354 
Review article.
Homann et al. 2005
355 
Review article.
Huxley et al. 2007
356 
Review article.
Key and Verkasalo 1999
357 
Review article.
Key et al. 2004
42 
Review article.
Kim et al. 2007
358 
Review article.
Klatsky 2001
359 
Review article.
La Vecchia 1989
360 
Review article.
Lands 1998
361 
Review article.
Ledermann 1955
362 
Review article.
Li and Lai 2009
363 
Review article.
Lieber 2000
364 
Review article.
Lindhal 1992
365 
Review article.
Longnecker 1995
366 
Review article.
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Study Reason(s) for Exclusion
Longnecker 1995
367 
Review article.
Lowenfels 1990
368 
Review article.
Mason and Choi 2005
369 
Review article.
Nagy 2004
9 
Review article.
Nanri et al. 2007
370 
Review article.
O’Hanlon 2005
35 
Review article.
Payne 1990
371 
Review article.
Perse and Cerar 2007
84 
Review article.
Porter 1993
372 
Review article.
Porter 1995
373 
Review article.
Poschl and Seitz 2004
24 
Review article.
Poschl et al. 2004
374 
Review article.
Pufulete et al. 2003
375 
Review article.
Purohit 2000
376 
Review article.
Rampersaud et al. 2002
377 
Review article.
Rogers and Conner 1986
378 
Review article.
Rogers et al. 1993
379 
Review article.
Rothman et al. 1995
380 
Review article.
Sakar et al. 2001
381 
Review article.
Salaspuro 1996
20 
Review article.
Salaspuro and Mezey 2003
382 
Review article.
Schatzkin and Longnecker 1994
43 
Review article.
Secretan et al. 2009
17 
Review article.
Seitz and Becker 2007
383 
Review article.
Seitz and Homann 2007
384 
Review article.
Seitz and Maurer 2007
385 
Review article.
Seitz and Poschl 1997
386 
Review article.
Seitz et al. 1994
387 
Review article.
Seitz et al. 2005
369 
Review article.
Seitz et al. 1998
388 
Review article.
Siegmund et al. 2006
389 
Review article.
Simanowski et al. 1995
390 
Review article.
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Study Reason(s) for Exclusion
Stoll 1999
391 
Review article.
Tan et al. 2006
392 
Review article.
Taylor and Rehm 2006
393 
Review article.
Thies and Siegers 1989
394 
Review article.
Tsigris et al. 2007
395 
Review article.
Ulrich 2007
396 
Review article.
Walker and Burkitt 1976
397 
Review article.
Wang 2003
398 
Review article.
Wang 2005
399 
Review article.
Weisburger et al. 1981
400 
Review article.
Weisburger 1998
401 
Review article.
Welsch 1985
402 
Review article.
Williams 1976
403 
Review article.
Winawer and Shike 1992
404 
Review article.
Wright et al. 1999
25 
Review article.
Wynder 1977
405 
Review article.
Wynder 1978
406 
Review article
Nozawa et al. 2006
407 
Study administered freeze-dried beer.
Martin et al. 2004
408 
Study administered Resveratrol, a polyphenol found in
grapes.
Gierer 1955
409 
Study did not look at cancer causation.
Briviba et al. 2002
410 
Study did not report on consumption/administration of
ethanol.
Caderni et al. 2000
411 
Study did not report on consumption/administration of
ethanol.
Cerda et al. 1999
412 
Study did not report on consumption/administration of
ethanol.
Depeint et al. 2006
413 
Study did not report on consumption/administration of
ethanol.
Diergaarde et al. 2003
259 
Study did not report on consumption/administration of
ethanol.
Dolara et al. 2005
358 
Study did not report on consumption/administration of
ethanol.
Farah 2005
414 
Study did not report on consumption/administration of
ethanol.
D-4
 
    
    
 
    
 
     
 
    
 
    
 
     
 
    
 
    
 
    
 
    
 
     
 
    
 
    
 
    
 
    
 
    
 
     
 
     
 
    
 
     
 
Study Reason(s) for Exclusion
Femia et al. 2005
415 
Study did not report on consumption/administration of
ethanol.
Gonthier et al. 2003
416 
Study did not report on consumption/administration of
ethanol.
Hall et al. 1991
417 
Study did not report on consumption/administration of
ethanol.
Kabat and Rohan 2007
418 
Study did not report on consumption/administration of
ethanol.
Kabat et al. 2007
419 
Study did not report on consumption/administration of
ethanol.
Lagiou et al. 2009
420 
Study did not report on consumption/administration of
ethanol.
Etique et al. 2004
421 
Study did not report on consumption/administration of
ethanol.
Linz et al. 2004
422 
Study did not report on consumption/administration of
ethanol.
Luceri et al. 2002
423 
Study did not report on consumption/administration of
ethanol.
Maciel et al. 2004
298 
Study did not report on consumption/administration of
ethanol.
Moon et al. 2006
424 
Study did not report on consumption/administration of
ethanol.
Morris and Seifter 1992
425 
Study did not report on consumption/administration of
ethanol.
Nozawa et al. 2004
426 
Study did not report on consumption/administration of
ethanol.
Nozawa et al. 2004
427 
Study did not report on consumption/administration of
ethanol.
Nozawa et al. 2005
428 
Study did not report on consumption/administration of
ethanol.
Peluso et al. 2008
429 
Study did not report on consumption/administration of
ethanol.
Reddy et al. 1997
430 
Study did not report on consumption/administration of
ethanol.
Robson et al. 2006
431 
Study did not report on consumption/administration of
ethanol.
Schrauzer et al. 1982
432 
Study did not report on consumption/administration of
ethanol.
Takechi et al. 2004
433 
Study did not report on consumption/administration of
ethanol.
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Wulf et al. 2004
434 
Study did not report on consumption/administration of
ethanol.
Yamagishi et al. 2002
435 
Study did not report on consumption/administration of
ethanol.
Slattery et al. 2009
58 
Study looked at tumor markers.
Gago-Dominguez et al. 2005
436 
Unrelated epidemiology study.
Gaudet et al. 2005
437 
Unrelated epidemiology study.
Giacosa et al. 2004
438 
Unrelated epidemiology study.
Lewis et al. 2003
439 
Unrelated epidemiology study.
Orita et al. 2004
440 
Unrelated epidemiology study.
Schatzkin et al. 1993
441 
Unrelated epidemiology study.
Visapaa et al. 1998
442 
Inhibition of intracolonic acetaldehyde production by
ciprofloxacin.
Vogel et al. 2007
184 
Title correction.
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